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Abstract  
Background and objectives 
Seafood is considered a natural part of a healthy and balanced diet. Seafood is an excellent 
source of high quality protein, and contains many essential nutrients like omega-3 fatty acids, 
vitamin D, B12, iodine, and selenium. At the same time it contains some environmental 
contaminants, such as polychlorinated biphenyls (PCBs), which may have undesirable health 
effects. The risk-benefit of seafood is therefore under debate, with focus on oily fish in 
particular. Based on this public debate the Norwegian Directorate of Health recently advised 
young, as well as pregnant women, to consume no more than two meals of oily fish per week 
over longer periods of time. This might reduce the foetal exposure to PCBs that can have a 
negative effect on development. The National Institute of Nutrition and Seafood Research 
(NIFES) did not support this advice, as it was based on contaminant data from 2004, and 
contaminant levels have decreased since then. In this project mothers’ seafood intake during 
pregnancy and postpartum was assessed, and serum concentrations of PCBs from both mother 
and child have been determined. The relationship between PCB-concentrations in mother and 
child and reported seafood intake was then evaluated. Confounding factors for body burden of 
PCBs, like BMI, age, breastfeeding, and parity, were also examined to see if they had an 
influence on the PCB-concentrations.  
Method 
This project was part of the prospective longitudinal population-based study “Nutrition, Mental 
Health and Infant Development” that took place in the municipality Fjell in Western-Norway, 
2010-2012. Blood was sampled from mothers in the 28th gestation week and at 3-, 6- and 12 
months after birth from both mother and child. Dietary habits of mothers were assessed by a 
seafood-food frequency questionnaire (seafood-FFQ), and dietary habits of the children were 
assessed by a 24-hour recall interview and an interviewer administrated FFQ. The following 
PCBs: PCB-118, PCB-138, PCB-153 and PCB-180 were extracted from 100 µl serum and 
analysed by High Resolution Gas Chromatography – High Resolution Mass Spectrometry 
(HRGC-HRMS). 
Results and conclusion 
The women in this study population consumed less seafood than the amount recommend by the 
Norwegian Directorate of Health. All four PCBs were detected in serum from both mother and 
child, at levels considerably lower than other European countries. Whereas breastfeeding in 
itself had little impact on the serum PCB-levels in mothers, breastfed children had increased 
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serum PCB-levels compered to not breastfed children. The serum PCB-levels increased with 
age and parity in non-breastfeeding and breastfeeding women respectively. Fish liver 
consumption was the only seafood that decisively had an impact on serum PCB-levels. When 
excluding fish liver consumers there were no relationship between maternal fish intake and 
serum PCB-levels in mother or child. Pregnant and young women should therefore increase 
their seafood intake to achieve the overall beneficial health effects, but avoid consumption of 
fish liver.
 v 
 
Sammendrag  
Bakgrunn og mål 
Sjømat er en naturlig del av et balansert og sunt kosthold. Sjømat er en meget god kilde til 
proteiner av høy kvalitet, og inneholder også mange essensielle næringsstoffer som omega-3 
fettsyrer, vitamin D, B12, jod og selen. Samtidig vet man at sjømat inneholder kontaminanter, 
som polyklorerte bifenyler (PCB), og disse kan ha en negativ helseeffekt. Det er derfor mye 
debatt rundt risiko-nytte analyser av sjømat, med spesielt fokus på fet fisk. Fet fisk spises 
regelmessig av mange, men inneholder noe PCB. Basert på denne debatten anmodet 
Helsedirektoratet nylig gravide og unge kvinner om å ikke spise mer enn to måltider fet fisk i 
uken over tid. Dette kan bidra til å redusere fosterets eksponering for PCBer som kan ha en 
negativ effekt på utviklingen. Nasjonalt Institutt for ernærings- og sjømatforskning (NIFES) 
støttet ikke denne anmodningen siden den er basert på data fra 2004, og nyere data viser lavere 
kontaminantnivå i dag. Dette prosjektet tar for seg mødres sjømatinntak i svangerskapet, og 
etter fødselen, og undersøker PCB-konsentrasjoner i serum hos både mor og barn. 
Konsentrasjoner av PCBer i mor og barn ble så sett på i sammenheng med fiskeinntaket. Mulige 
faktorer som kan påvirke PCB-konsentrasjonen, som BMI, alder, amming og tidligere barn, ble 
også sett nærmere på.  
Metode 
Denne studien er en del av den prospektive longitudinelle populasjonsbaserte studien 
”Kosthold, Mental Helse og Spedbarns Utvikling” som foregikk i Fjell-kommune i Vest-Norge, 
2010-2012. Blodprøver ble samlet inn fra mor i uke 28 i svangerskapet, og ved 3-, 6- og 12 
måneder etter fødselen for både mor og barn. Spisevanene til mødrene ble undersøkt ved hjelp 
av sjømat-frekvensskjema, og spisevanene til barna ble undersøkt med 24-timers intervju 
metoden og et intervjuer administrert matfrekvensskjema. De følgende PCBer: PCB-118, PCB-
138, PCB-153 og PCB-180 ble ekstrahert fra 100 µl serum og analysert med High Resolution 
Gas Chromatography – High Resolution Mass Spectrometry (HRGC-HRMS). 
Resultat og konklusjon 
Sjømatinntaket i denne studiepopulasjonen var lavere enn det som er anbefalt av Norske 
helsemyndigheter.  Alle de fire PCBene ble funnet i serum hos mor og barn, men nivåene var 
betraktelig lavere enn nivåer i andre europeiske land. Ammefrekvens hadde liten effekt i seg 
selv på serum PCB-nivåer i mor, mens ammede barn fikk en økning i PCB-nivåer sammenlignet 
med barn som ikke var ammet. Serum PCB-nivåene i mor økte med alderen og ble redusert hos 
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de som hadde biologiske barn fra før i henholdsvis ikke-ammende og ammende mødre. 
Fiskelever var eneste sjømatkilden som påvirket serum PCB-konsentrasjonene. Ekskluderer 
man de som spiser fiskelever var det ingen sammenheng mellom sjømatinntak og serum PCB-
konsentrasjoner hos mor eller barn. Gravide og unge kvinner bør derfor øke sjømatinntaket for 
å oppnå de gunstige helsefordelene, men samtidig holde seg unna fiskelever. 
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1. Introduction 
1.1. Background 
In the summer of 2013 several Norwegian newspaper articles concerning environmental 
contaminants in fish and their impact on human health were published (Aftenposten, 2013; VG, 
2013). The focus was especially on consumption of oily fish among young or pregnant women, 
as well as children. Since it is believed that it is in the foetus and children these contaminants 
have the potential to do most harm (Lanting et al., 1998c; Patandin et al., 1999; Schantz et al., 
2003). The Norwegian Health Authority clarified after this that young, as well as pregnant 
women should limit their consumption of oily fish to two meals per week over time (The 
Norwegian Directorate of Health, 2013). This statement is based on a report from 2006, that 
use data from 2004 (VKM, 2006). Since this report came out some of these environmental 
contaminants have declined in nature. The introduction of more vegetable based feed to 
Norwegian farmed salmon  has also contributed to lowering the content of PCBs in this fish 
(NIFES, 2013a). Based on this the National Institute of Nutrition and Seafood Research 
(NIFES) stated that “The present content of environmental pollutants in fatty fish does not 
support a limit of two meals of fatty fish a week for pregnant women” (NIFES, 2013c).  
It is important to know what level of contaminants actually exist in the Norwegian population. 
Only when these levels are established is it possible to say something about the potential harm 
from these contaminants in seafood. In this project mothers’ seafood consumption during 
pregnancy and postpartum was assessed, and serum concentrations of polychlorinated 
biphenyls (PCBs) from mothers’ and their children have been determined. The relationship 
between these PCB-concentrations and reported seafood consumption was then evaluated. 
Potential confounding factors to the serum PCB-concentrations were also explored.  
This project followed mothers and children from pregnancy to 12 months after birth and focused 
mainly on seafood and serum PCB-levels, and their respective positive and potential negative 
effect on mother and child in this period. 
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1.2 Seafood 
Seafood, including fish, contains important nutritional compounds that are beneficial to human 
health. However, it can also contain undesirables such as environmental contaminants and other 
substances with a potential negative impact on health. The level and types of nutrients and 
contaminants in the seafood depends on many factors, such as age, life stage (developmental, 
reproductive), species, feed, season and location (VKM, 2006).  
1.2.1 Positive nutritional contributions from seafood 
Fish is an excellent source of high quality protein, containing all the essential amino acids, with 
an average of 15-20 g protein/100 g fish (VKM, 2006). Oily fish (>8g fat/100g filet), is the 
most important dietary source of vitamin D and the marine omega-3 polyunsaturated fatty acids 
(PUFA) in the Norwegian diet (VKM, 2006). Other important nutrients in fish are especially 
iodine, but also B12, iron, and selenium (Nasjonalt Råd for Ernæring, 2011). Cod liver oil also 
contain a substantial amount of vitamin A. However, the content of vitamin A Norwegians get 
from fish alone is not significant (VKM, 2006).  
Vitamin D is fundamental for maintaining normal blood levels of calcium and phosphate. 
This is important for bone mineralization, muscle contraction and nerve function (FAO/WHO, 
2001a; Pludowski et al., 2013).  
The marine omega-3 polyunsaturated fatty acids (PUFAs) are eicosapentaenoic acid (EPA), 
docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA). These are important for foetal 
growth and neurological development. About 50% of the human brains dry weight consists of 
lipids, and about 50% of these lipids are phospholipids with high proportions of DHA (Innis, 
2003). In the third trimester of pregnancy the foetus alone consumes 67 mg/day of omega-3 
PUFA (Innis, 2003). It is therefore important that the mother have an intake that covers both 
her and the foetus’s need for omega-3 PUFAs. DHA is also important for proper eye sight as it 
is the main PUFA in the outer parts of the rods and cones in the eye’s retina, it is therefore vital 
for transmission of visual signals (Innis, 2003). High intake of marine omega-3 PUFAs (DHA 
and EPA) during pregnancy has also been linked to a lower risk of postpartum depression 
(Markhus et al., 2013b; Vaz et al., 2013).  
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Iodine is a component of the thyroid hormones thyroxine (T4) and triiodothyronine (T3). It is 
essential for brain development, growth and metabolism, not only for the foetus, but throughout 
life (FAO/WHO, 2001b). The foetus is entirely dependent on the mother’s thyroid hormone 
supply for the first trimester, and it is therefore important that the mother has an adequate level 
of iodine in this period (Zimmermann, 2009). Bath et al. (2013) found that mothers with low 
iodine-to-creatinine ratio were more likely to have children in the lowest quartile of the verbal 
intelligence quotient (IQ), reading accuracy, and reading comprehension. This study included 
omega-3 PUFA as a confounder, and still found the same results. 
There are some studies that focus on fish consumption solely and find positive effects from this 
in mothers and children. Neurodevelopment in children is positively associated with mothers’ 
seafood intake, even when corrected for negative effects from mercury in the same study 
(Suzuki et al., 2010). Different results were found in an American cohort, where visual 
cognition in infants was better among children of mothers’ with a high fish consume only when 
the fish was low in mercury (Oken et al., 2005). Williams et al. (2001) found that children of 
mothers that consumed oily fish at least once every 2 weeks during pregnancy had better visual 
stereoacuity at 3.5 years than children from mothers that did not consume oily fish. In the same 
cohort (Avon Longitudinal Study of Parents and Children (ALSPAC)), it was found that a 
higher fish intake by mothers during pregnancy was associated with higher mean developmental 
scores. Children that consumed fish once a week at 6 and 12 months also had a slightly better 
mean developmental score than those that did not consume fish (Daniels et al., 2004). Mothers 
who consumed fish less than 3 times per week were found to have increased risk of their child 
being in the lowest quartile of verbal IQ (Hibbeln et al., 2007). This risk increased with sinking 
amount of fish consumed. Fish consumption (1-3 times per week) has also been associated with 
less anxiety during pregnancy (Vaz et al. 2013). High consumption of especially lean fish can 
also seem to dercrease the risk of giving birth to a small baby (<2500g) (Brantsaeter et al., 
2012). However intake of, especially, oily fish have been linked with prevention of 
cardiovascular heart diseases (CHD) and decreased deaths caused by CHD (Simopoulos, 2002; 
Whelton et al., 2004; Raatz et al., 2013). 
1.2.2 Negative contaminant contributions from seafood 
Fish may also contain a certain degree of environmental contaminants that the fish accumulate 
throughout life. Types of undesirables normally found in fish are methyl mercury, insecticides, 
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and organic contaminants like polychlorinated biphenyls (PCBs) (VKM, 2006). This project 
focuses solely on PCBs, which are one of the most prominent contaminants in fish because of 
their known persistence in nature and their lipid accumulating abilities.  
1.3 Polychlorinated Biphenyls 
PCBs are man-made industrial chemicals that were first synthesized around 1920 (Crinnion, 
2011). PCBs occurs in mixtures and have some chemical qualities that make them useful for 
industrial purposes. They are known to be resistant to breakdown by acids, bases, and oxidation, 
and are non-flammable (Broadhurst, 1972). PCBs also have excellent isolating and cooling 
capabilities and were therefore actively used as heat transfers and cooling agents in electric 
transformers (Crinnion, 2011). Furthermore, they have been used in electrical appliances, 
windows, copy paper, pesticides, paints, newsprints, as plasticizers, and as lubricants in 
hydraulic systems (Ross, 2004). 
PCBs consist of two phenyl rings connected to each other (the biphenyl molecule) with 1-10 
chlorine (Cl) atoms connected to the phenyl rings (Crinnion, 2011). The chemical formula is 
C12H10-nCln. There are 209 different structures, of these 130 are normally found in different, 
formerly industrially produced, PCB-mixtures (WHO, 2000). PCBs are split into two groups; 
the 12 “dioxin-like” (dl-PCBs) and the 197 “non-dioxin-like” (n.dl-PCBs) (Crinnion, 2011). 
Dl-PCBs share a similar structure and toxicity with polychlorinated dibenzo-p-dioxins (PCDD) 
(Crinnion, 2011). As illustrated in Figure 1.1 most PCBs have their Cl-atoms distributed evenly 
between the two phenyl molecules. Cl-atom in position 2 and 6 makes the PCB an ortho-PCB 
(EEA, 2001). With more than one Cl-atom in these positions the biphenyl is forced into a 
twisted position. Non-ortho-PCBs also exist, but are quite rare (EEA, 2001). PCB-138, -153 
and -180 are ortho-substituted non-planar PCBs that are also known as phenobarbital-like PCBs 
(EEA, 2001). It is the Cl-atoms and the carbon-chloride (C-Cl) bond that makes PCBs so 
environmentally persistent, and gives the molecule its stability against hydrolysis (Matthews et 
al., 1980; Chu et al., 2006). The more Cl- or other substitutions connected to the C-atoms in the 
phenyl ring, the greater resistance against biological and photolytic degradation of the molecule. 
Intrinsic human elimination half-life approximations, that account for effects of ongoing 
exposure and fluctuating body-weight, for the PCBs studied in this project (Figure 1.1) are 9.3 
years for PCB-118, 10.8 years for PCB-138, 14.4 years for PCB-153 and 11.5 years for PCB-
180 (Ritter et al., 2011).  
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Figure 1.1 Biphenyl skeleton and the PCBs examined in this study (PCB-118, -138, -153, -180) 
Source: adapted from ChemSpider 
The European Food Safety Authority (EFSA) normally looks at six indicator n.dl-PCBs (PCB- 
28, - 52, -101, -138, - 153 and – 180) (PCB6), that normally constitutes 50% of the total n.dl-
PCBs found in food (EFSA, 2010). From the analysis of these 6 PCBs they found that PCB-
153 and PCB-138 constituted about 50% of these, followed by PCB-180, -28, -101 and -52 in 
that order. Sometimes PCB7 is used instead of PCB6, which include PCB-118. Other studies 
have also found that the main congeners are PCB-138, -153 and -180, these are therefore 
suitable to use as indicators on PCB-status, and are often summed to represent half the body 
burden of PCBs, or doubled after summation to represent the total body burden  (Grandjean et 
al., 1995; Nakamura et al., 2008). 
It took about 50 years before the health dangers of using PCBs became apparent. Hence, 
between 1972 and 1980 a production ban on PCBs was implemented in many countries (EEA, 
2001). In 2001 the “Stockholm Convention on Persistent Organic Pollutants” launched an 
international production ban on PCBs (Crinnion, 2011). It is estimated that 1.3 million tons of 
PCBs were produced between 1930 and 1993, but the true number is likely even higher (Breivik 
et al., 2002). To this day there are persistent PCBs in nature because of their long half-life, and 
also from leakage of PCBs from old appliances that have not been discarded properly (Lu et 
al., 2012).  
PCBs are part of a bigger group of pollutants called persistent organic pollutants (POPs). These 
all have long half-life’s that allows them to persist in the environment and migrate through air, 
soil, water and sediments, and accumulate in the food chain (Jones et al., 1999). When exposed 
to higher environmental temperatures POPs tend to transfer to a gaseous phase and can emigrate 
from the waterbodies and land they have been introduced to into the atmosphere (Jones et al., 
1999). When PCBs are anaerobicly degraded in nature, one of the outcomes are declorination, 
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which might lead to a higher degree of volatility (Chiarenzelli et al., 1996). They can then 
follow the atmospheric air currents for long, or short, periods of time before they are adsorbed 
to atmorpherical particles and are deposited (Jones et al., 1999). Deposition can occur when the 
PCBs get to a higher latitude with colder temperature, or when entering colder climates (Jones 
et al., 1999). Rain showers can also deposit PCBs back to nature (Jones et al., 1999). This 
atmospheric transport is the reason behind the widespread distribution and why PCBs can be 
found in polar regions like the Arctic and Antarctica (Wania et al., 1996). The vaporisation of 
PCBs is highest when it evaporates toghether with water (Chiarenzelli et al., 1997). In colder 
climates this water evaporation is lower than in warmer climates, and PCBs are therefore more 
easily accumulated in these climates.  
PCBs are hydrophobic and fat soluble and therefore accumulate in adipose tissue, especially in 
storage lipids like triglycerides and cholesterol esters which they have a higher affinity for than 
phospholipids and cholesterol (Lanting et al., 1998b). Generally PCBs are very lipophilic 
compounds, with increasing lipophilicity following the degree of chlorination (Safe, 1990). 
PCBs will therefore accumulate in fish and animals, and biomagnify up the food chain when  
predators eat their prey (El-Shahawi et al., 2010). Some of the highest concentrations of PCBs 
are found in livers of lean fish and in fillet of oily fish like mackerel, salmon and trout (Table 
1.1). Seafood is the biggest source of PCB exposure for Norwegians, accounting for 41% of all 
dioxin-like compound, and 49% of PCB-153 intake (Caspersen et al., 2013). Other sources can 
be cereals, milk products, and eggs, but PCB exposure from these sources are low among 
pregnant Norwegians (Caspersen et al., 2013). PCBs are taken up in the human body by 
enterocytes in the gastrointestinal tract by co-absorption together with dietary lipids in mixed 
micelles (Dulfer et al., 1996). They are then packed in chylomicrons with resynthesized lipids 
and transported via the lymphatic system to the blood veins (Kelly et al., 2004; Iqbal et al., 
2009). In human infants over 90% of ingested PCBs get absorbed (McLachlan, 1993; Dahl et 
al., 1995).  
Table 1.1 Declining mean concentrations for PCB7 in Norwegian seafood 
PCB7 (µg/kg) 
 1994/1995 2000/2001 2006/2007 2008/2009 2010/2011 
Atlantic Salmon (farmed) 17 15* 8.9 6.7 5.1 
Atlantic Cod, filet (wild) 1 0.6 0.38 0.1  
Atlantic Cod, liver (wild)   113 92  
Greenland Halibut   32 37 23.8 
Rainbow Trout (farmed)   12 6.4 (3.1-4.5)a 
Prawn (without shell) 1 0.4 0.9* 0.8 0.3* 
*1994, 2001, 2007, 2009, 2010                                                                                   Source:(NIFES, 2013b)  
arange of concentrations 
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Several exposure assessments now point toward declining levels of both dioxins and PCBs in 
nature and humans (Axmon et al., 2008; Kvalem et al., 2009; EFSA, 2012b). EFSA states that 
the dietary exposure to dioxins and dl-PCBs has decreased between 16 and 79%, while n.dl-
PCBs have decreased between 2 and 75%, depending on the population group, from 2002 to 
2010 (EFSA, 2012b). This decrease can also be seen in human breast milk. The concentration 
of PCB6 in breast milk from Norwegian mothers is now less than one third of what it was in 
1986 (Figure 1.2) (FHI, 2009). 
 
Figure 1.2 Declining PCB6-concentration in breast milk: Time trend for PCB6 in Norwegian breast milk from 1986-2005. 
Before 2005 these are based on a pooled sample, 2005 is median from about 50 individual samples. 
Source: (FHI, 2009) 
Dioxin and dl-PCBs bind to the same receptor protein, the aryl hydrocarbon (Ah) receptor. This 
is thought to be the main mediator for the toxic effects from dioxin and dl-PCBs. The Ah-
receptor is, after binding to the compounds, transported in to the nucleus where it can affect 
gene expression that again affects several biological processes (Mimura et al., 2003). The 
2.3.7.8-tetrachlorodibenzo-p-dioxin (TCDD) is the most toxic of the dioxins and is the dioxin 
that the other dioxin-like compounds are measured against (WHO, 2000). The toxic potency of 
the compound correlates to its affinity for the Ah-receptor (Ahlborg et al., 1994). This toxicity 
is expressed in toxic equivalency factors (TEF) in relation to TCDD which has a TEF of 
1(Ahlborg et al., 1994). PCB-118, which is examined in this project, has a TEF of 0.0001 
(Ahlborg et al., 1994). The TEF of a congener is multiplied with the amount of the congener in 
a sample, and then added together with the other congeners TEFs to get the total toxic 
equivalence (TEQ) in the sample.  
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The most prominent effects from n.dl-PCBs are most likely from disruption of endocrine 
systems, or components in endocrine systems. These components can be hormones, carrier 
proteins, metabolic enzymes, receptors, endocrine glands, and feedback regulators (Brouwer et 
al., 1999). During the metabolizing of PCBs by the microsomal cytochrome P-450 system they 
are hydroxylated (OH) (Safe, 1993). Some OH-PCBs have shown affinity to endocrine 
receptors and proteins, and have been shown to compete with estrogen for their receptor 
(Korach et al., 1988; Connor et al., 1997; Gierthy et al., 1997) and thyroxin for their plasma 
binding protein (Brouwer et al., 1990; Lans et al., 1993). Endocrine systems that can be 
disrupted by PCBs are neurodevelopment, reproductive systems, the immune system and 
induction of endocrine-sensitive tumours (Brouwer et al., 1999). Some PCBs, and intermediate 
products from the formation of OH-PCB, have been found to covalently bind DNA, making 
DNA-adducts. These are therefore suspected of being carcinogenic or mutagenic agents (Buff 
et al., 1989; Dubois et al., 1995; Oakley et al., 1996). Studies on rats also indicate that some 
PCBs can inhibit calcium uptake in microsomes and mitochondria (Kodavanti et al., 1996).  
A tolerably weekly intake (TWI) has been set to 14 pg WHO-toxic equivalence factor/kg 
bodyweight/week (TEQ/kg b.w./week) for dioxins and dioxin-like compounds (SCF, 2001). In 
the Norwegian Fish and Game study the median intake of dioxins and dl-PCBs from fish and 
seafood was as low as 4.7 pg TEQ/kg b.w./week (VKM, 2007). The Norwegian Scientific 
Committee for Food Safety has concluded that this TWI for dioxins and dl-PCBs will also 
protect against adverse effects from PCBs including n.dl-PCBs, given the composition and 
concentrations that were found in Norwegian food in 2008 (VKM, 2008). Epidemiologic 
studies suggests, that some damage can occur to the neurological and immune systems to foetus 
and children if the mother has 1 µg or more PCB/g body fat (VKM, 2008). This concentration 
can be obtained if the mother consumes 40 ng PCB/kg body weight per day for her whole life, 
or about 20 ng PCB6/kg b.w. of PCB6 (VKM, 2008). The median intake per day from the 
Norwegian Fish and Game study has been calculated to be about 4.3 ng PCB6/kg b.w. for those 
with average fish consumption, or about 6.4 ng PCB6/kg body weight for those that are high 
consumers of fish (Kvalem et al., 2009). This is inside the estimated weekly average in Europe 
that ranges between 26.6-80.5 ng PCB6/kg bodyweight per week for n.dl-PCBs, and 3.5-11.9 
pg TEQ/kg bodyweight per week for dioxins and dl-PCBs (EFSA, 2012b).  
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1.3.1. Health implications from PCBs 
In humans the PCBs get transferred prenatally to the foetus through the placenta, and are also 
secreted postnatally with fat globules in breast milk. Breastfeeding infants can therefore have a 
daily exposure up to two orders of magnitude higher than adults on a b.w. basis (EFSA, 2005). 
Postnatal body burden of PCBs will increase with the duration of breast-feeding (Sioen et al., 
2013). Most negative health effects are observed from prenatal contamination, likely due to 
higher neurodevelopmental sensitivity in this period (VKM, 2013). For adults the long term 
effects can possibly affect reproduction systems, as well as give a possible increased cancer-
risk (Brouwer et al., 1999).  
Neurologic effects 
Several studies have concluded that early exposure to PCBs can be linked to neurological 
dysfunction and impaired cognitive behaviour in the first years of life (Lanting et al., 1998c; 
Patandin et al., 1999; Schantz et al., 2003). Some of the neurological outcomes reported from 
studies considering PCBs are verbal-, numerical-, and short-term memory deficits, visual 
fixation-time problems, and psychomotor delay (only until 2 years) (Schantz et al., 2003). 
Jacobsen et al. (1996) found that children of mothers with the highest concentrations of PCBs 
(at least 9.7 ng total PCBs/ml maternal serum) were more easily distracted, had poorer verbal-
, word-, and reading comprehension, and also lower IQ at 11 years of age than those with lower 
in-utero PCB exposure. These observations were supported by a Dutch study, which 
documented poorer cognitive skills at 42 months from children of mothers with the highest 
concentrations of PCBs (Patandin et al., 1999). The perseverance of these negative neurological 
effects remain unclear as Lanting et al. found neurological effects linked to PCBs at 18 months, 
but not at 42 months (Lanting et al., 1998c). Patandin et al. (1999) also looked at prenatal dl-
PCBs and dioxin effect at 42 months and found no link to cognitive behavioural problems 
associated with these. A more favourable home environment can seem to combat these 
outcomes. This can include a higher degree of breastfeeding, as well as parents with a higher 
education (Patandin et al., 1999; Walkowiak et al., 2001; Schantz et al., 2003).  
Maternal OH-PCB-concentrations have been found to be significantly positively associated 
with thyroid stimulating hormones (TSH) in new-borns (Salay et al., 2009). TSH is important 
for the production of thyroid hormones (thyroxin and triiodothyronine). These are essential for 
the neurodevelopment in new-borns. Thyroid hormones are needed for stimulating the 
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development of neuronal and glial cell proliferation and differentiation (Porterfield et al., 1993). 
A high TSH indicates low levels of thyroid hormones because the thyroid hormones send a 
negative feedback to lower the production of THS, and this might suggest underdeveloped 
thyroid functions (Salay et al., 2009; Hisada et al., 2013).  
Birth weight 
There are conflicting studies on whether PCBs can be associated with birth weight. In the 
Norwegian mother and child study (MoBa) a high total PCB concentration in mothers was 
negatively associated with foetal weight and length (Papadopoulou et al., 2013). However, this 
negative association decreases with increased seafood intake (Papadopoulou et al., 2013). 
Similar negative associations were found by a large meta-analysis of 12 European birth cohorts 
(Govarts et al., 2012). They found that birth weight decreased by 150 g per 1 µg/L increase of 
PCB-153 in cord-serum blood (Govarts et al., 2012). Contrariwise a smaller Swedish cohort 
study found that the di-ortho PCBs (PCB-138, PCB-153, and PCB-180) were significantly 
associated with increased birth weight (Lignell et al., 2013). The MoBa study (Papadopoulou 
et al., 2013) had a much higher number of participants than the Swedish cohort (Lignell et al., 
2013) (50 651 to 413). MoBa (Papadopoulou et al., 2013) also analysed a greater number of 
PCBs (6 n.dl-PCBs and 12 dl-PCBs).  
1.4 Risk-benefit assessment  
Risk assessment is a systematic method that aims at quantifying the risk of a known hazard. 
Risk assessment of contaminants in food is dependent on both how humans get exposed for the 
contaminants, via food and other routes, and the contaminants potential for causing adverse 
health effects (Alexander J et al., 2012). The risk is then the probability for adverse health 
effects to occur at a set exposure (Alexander J et al., 2012).    
Risk-benefit assessments study the beneficial health effects of some substances in fish and 
seafood and confronts the observed benefits with the negative outcome from other substances. 
This is difficult, and depends not only on the different nutrients and contaminants in fish as 
mentioned above, but also on how a person absorbs nutrients and contaminants, as well as 
genetics, and overall diet.  Amount and type of fish eaten over time is what will determine if 
the fish has a positive or negative effect on human health. The toxicity is a consequence of the 
body burden that is built up over time, more than recent dietary exposure (VKM, 2006).  
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Risk-benefit assessments can be carried out on nutrients and contaminants in fish and seafood 
by comparing tolerable upper levels (UL) and nutrient recommendations for the nutrients and 
tolerable weekly intakes (TWI) for contaminants with national intake estimates (VKM, 2006).  
The UL states the nutrient level that a person can ingest without risking a negative health effect. 
The TWI is set to give good protection against toxic effects and is based on the lowest dose that 
does not cause a toxicological effect in animal studies. Sensitive groups may have different 
assessment than the general population, and it is important to separate out these groups.      
Several risk-benefit assessments have been undertaken for seafood by different countries 
(Fødevaredirektoratet, 2003; Scientific Advisatory Committee on Nutrition, 2004; EFSA, 2005; 
VKM, 2006; Institute of Medicine, 2007; Livsmedelsverket, 2007). The various assessments 
concluded that fish consumption inside the recommendations are beneficial for human health, 
and especially some sensitive groups, like pregnant women, are advised to include fish in their 
diet. However, pregnant women are recommended to take special precautions for some seafood 
products.  
1.5 Dietary advice for pregnant and breastfeeding women concerning 
seafood intake  
To ensure the recommended daily dosage of DHA and EPA, pregnant and breastfeeding women 
should consume seafood (The Norwegian Directorate of Health, 2001; 2009). In 2013 the 
Norwegian Directorate of Health specified that young and pregnant women should stay within 
2 meals of oily fish per week over time (The Norwegian Directorate of Health, 2013). Based 
on newer research NIFES have made a statement saying that it is safe to consume more than 
two meals of oily fish per week, even for pregnant women (NIFES, 2013c).  
The Norwegian Food Safety Authority provides dietary warnings for the public based on health 
risk assessments conducted by the Norwegian Scientific Committee for Food Safety (VKM) 
(VKM, 2006). Seafood with higher concentrations of environmental contaminants exist. The 
general public and especially vulnerable groups should limit their intake of these. For pregnant 
women this includes all pike and perch over 25 kg, trout over 1 kg, arctic char over 1 kg, 
Greenland halibut over 3 kg, brown crabmeat, shark, swordfish, fresh tuna, whale meat, seal 
meat, fish liver, bread spreads made from fish liver, and seagull eggs (The Norwegian 
Directorate of Health, 2009; The Norwegian Food Safety Authority, 2010; 2011a;, 2011b). 
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Fish liver is traditionally eaten in many coastal communities, and is the main ingredient in roe 
liver pate products such as Svolværpostei and Lofotpostei. Fish liver and seagull eggs are 
especially high in PCBs. From the MoBa study it was found that pregnant women who 
consumed seagull eggs and fish liver products had a much higher level of PCB-153 compared 
to those that did not consume them (Caspersen et al., 2013). Oily fish alone did not cause a 
disturbingly high intake of PCBs in the MoBa study (Caspersen et al., 2013).  
1.6 Dietary advice for infants 
Infants should be exclusively breastfed for the first 6 months, after 6 months other foods can be 
introduced to keep up with the child’s nutritional needs (The Norwegian Directorate of Health, 
2001). It is recommended to continue breastfeeding throughout the first year. Through breast 
milk the child will acquire all the nutrients needed, including omega-3 PUFAs, however 
contaminants will also be transferred from mother to child through breastfeeding (VKM, 2013). 
VKMs recent risk-benefit assessment for breast milk states that the benefits from breast milk 
clearly outweigh any risk of impaired neurodevelopment that might come from contaminants 
in breast milk (VKM, 2013).  
Infant formula is an alternative available for mothers that are not able to breastfeed, or if the 
child needs more milk than the mother is able to supply (VKM, 2013). Tests on infant formula 
do find some PCBs there, but the concentrations are low, and the estimated dietary exposure is 
lower for formula fed infants than breastfed infants (Weijs et al., 2006; Loran et al., 2009; 
Pandelova et al., 2011; EFSA, 2012a). When other foods get introduce these will also contribute 
to the intake. For PCB it is particularly the consumption of fish and some food jars that 
contribute, but still the intake estimate is lower than for those that are exclusively breastfed 
(Weijs et al., 2006; Pandelova et al., 2011; EFSA, 2012a).  
It is also recommended to give D-vitamin drops or cod liver oil (2.5 ml) to infants from 4 weeks 
of age to ensure a sufficient vitamin D status (The Norwegian Directorate of Health, 2001). By 
choosing cod liver oil the infant would also acquire marine omega-3 PUFAs. The amount of 
cod liver oil should be increased from 2.5 to 5 ml from 6 months. Norwegian cod liver oil is 
purified for PCBs. In 2010-2011 the concentrations in 14 fish oil samples were measured at 
NIFES and these were between 0.1 -83 µg PCB6/kg oil (NIFES, 2011b). These concentrations 
are therefore well below the 200 µg PCB6/kg oil limit set by the European Commission (EU, 
2006, 01.09.2012; NIFES, 2011b).  
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1.7 Fish intake in Norway 
The Norwegian Directorate of Health recommend eating fish for dinner 2-3 times per week 
(150-200g/portion), and about 200 g should be oily fish (salmon, mackerel or herring) 
(Nasjonalt Råd for Ernæring, 2011).   
In the national dietary study Norkost 2010-2011 the average consumption of pure fish was 308 
g for women and 448 g for men per week (The Norwegian Directorate of Health, 2012). Less 
than ¼ of the questioned population consumed the recommended 200 g of oily fish per week, 
with women consuming on average 154 g, and men 203 g (The Norwegian Directorate of 
Health, 2012). In MoBa the average intake was 252 g/week of total seafood, 140 g/week of lean 
fish, 84 g/week of fatty fish and 28 g/week of shellfish (Brantsaeter et al., 2012). 
Norwegians also use fish as a spread on bread. The normal choices are mackerel in tomato 
sauce, smoked salmon, shrimps or fishcake. One portion of fish as bread spread is 
approximately 25 g, thus 6 portions of fish spread equals one dinner portion.  
1.8 Dietary assessment 
There are different ways to assess food intake among a study population. The most commonly 
used methods are dietary records, recall interviews and FFQ (Block, 1982; Stumbo, 2013). 
Dietary records, with weighed or measured intake, are often considered the most accurate 
approach for the intake of the period recorded. Recall interviews can be for 24-hours or a certain 
number of days. Here the exact intake over the questioned period is recorded by an interviewer. 
24-hour recall is easy to recall with greater accuracy, whereas longer periods of recall give 
greater uncertainty (Block, 1982). However dietary records and recall interviews are not always 
representative for the typical long term intake. FFQs were developed to get a better overview 
of the long term intake in a study population (Stumbo, 2013). These can be based on frequency 
of food consumption in a year or for shorter periods. It is important to get the FFQ validated to 
be sure that the reported intake is in correlation with the actual intake. Different biomarkers 
measured in blood are often used for this purpose.     
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1.9 Aims of the study 
This project is part of a study that focuses on the importance of seafood consumption during 
pregnancy and the nursing period. There are few studies on PCB-levels in infants. Serum 
samples from both mother and child were used in this project to determine the concentration 
levels of PCBs in a Norwegian coastal community.  
Main hypothesis of this project: 
 Maternal fish consumption increase serum PCB-concentrations in mother and child.  
Specific aims of the project are: 
 How is the seafood consumption in this study population during pregnancy and 
postpartum compared to the recommendations? 
 Is it possible to detect PCB-118, -138, -153 and -180 in very small volumes of serum 
from mother and child? 
 What are the current levels of PCB-118, -138, -153 and -180 in serum for a selected 
group of Norwegian mothers and their children? 
 Do the maternal serum concentration of PCB-118, -138, -153 and -180 correlate with 
the serum concentration in the child?  
 Does BMI, age, parity and breastfeeding have an impact on serum levels of PCB-118, -
138, -153 and -180?  
 Do mothers consuming fish liver or roe liver pate, elevated in POPs, have a higher serum 
concentration of PCB-118, -138, -153 and -180?
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2. Materials and Methods 
2.1 Design 
This project was part of a prospective longitudinal population-based study called “Nutrition, 
Mental Health and Infant Development” (NMID). The aim of the study was to assess 
associations between seafood intake, maternal mental health, and infant development. The 
study took place in the municipality Fjell outside Bergen in Norway, and was a collaboration 
between the Regional Centre for Child and Youth Mental Health and Child Welfare (RKBU 
West), Uni Health and the National Institute of Nutrition and Seafood Research (NIFES). 
The project fulfilled the Declaration of Helsinki ethical principles for medical research 
involving human subjects as presented by The World Medical Association (WMA) in 1965, 
and revised in 2008 (WMA, 2013). The project was reported to and approved by the Regional 
Committees for Medical Health Research Ethics (REC West, ref.nr: 2009/570/REC. project nr: 
083.09) and the Norwegian Social Science Data Service (NSD, ref.nr: 21904). The master 
project was financed by NIFES and the University of Bergen.  
2.2 Participants and recruitment 
Pregnant women who were to give birth between 2010 and 2011 in Fjell were the target 
population for this study. They were recruited by their doctor or midwife between 24th and 28th 
gestation week at their paediatric clinics, or by their public health nurse at the local health care 
centre within three months postpartum in the period September 2009 to June 2011 (Markhus et 
al., 2013a). 
No exclusion criteria were given. Every participant gave written consent before inclusion and 
was free to withdraw from the study at all times without giving any reason. They were also 
informed that all biological material obtained in the study would be stored in a biobank at 
NIFES until destruction in 2015, and that all registered data would be retained until 2028.   
2.3 Data collection 
Dietary data (seafood-FFQ, general FFQ) and biological samples (blood, hair and urine) were 
collected from the mothers during the 28th gestation week, then at 3-, 6- and 12 months after 
birth.  Blood and hair were sampled from the children at 3-, 6- and 12 months of age. Dietary 
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recall was done by a 24 hour recall interview at 3-, 6- and 12 months. An interviewer 
administrated FFQ was also completed at 6- and 12 months (Appendix 1).  
2.3.1 Assessment of seafood intake 
Self-reported dietary data was reported by the mothers through a validated short seafood-FFQ 
(Dahl et al., 2011; Markhus et al., 2013a). This is a short questionnaire about habitual fish 
intake, as well as some general information about the dietary practice. This seafood-FFQ has 
shown strong correlations between reported intake of seafood and omega-3 supplements to the 
level of marine omega-3 PUFAs in erythrocytes (Dahl et al., 2011).  
The seafood-FFQ was sent out electronically by e-mail and answered through “Questback.com” 
around the 28th gestation week and at 3 months postpartum. At 6 and 12 months postpartum the 
seafood-FFQ was posted to the participants as a paper version. The first two seafood-FFQs 
from 28th week in pregnancy and 3 months after birth were automatically generated as a 
Statistical Package for the Social Sciences (SPSS), but the last two from 6 and 12 months had 
to be implemented by hand. 
The seafood-FFQ (Appendix-1) included questions about normal intake and frequency of 
seafood through dinner, snacks, salads and sandwich spread for the last three months. The 
questionnaire was split into two parts. The first part was about average frequency of seafood 
consumption. The frequency intervals were from never to over 5 times per week for seafood as 
dinner and for spreads (used on sandwiches, in salads or as a snack). Five different portion sizes 
were available to choose from, ranging from half a portion up to three portions. One portion 
was defined as 150 g of fish. There were two summarized questions on frequency of seafood 
as dinner and as spread. The type of seafood and spread were then specified in further questions. 
Open spaces for items not included made it easier for the participants to describe their diet. 
There was also one question concerning consumption of liver and roe. The second part included 
questions regarding other dietary sources of PUFAs and vitamin D (butter, margarine, cooking 
fat). Other questions focused on use of supplements, amount of fruit and vegetables, 
breastfeeding, medicines, lifestyle (interest in healthy eating, exercising), anthropometric and 
demographic factors as well as height, weight and previous births. Fish oil intake were separated 
into liquid or capsules and defined as teaspoon (3ml), child’s spoon (5ml) and tablespoon 
(10ml) or 1-2, 3-4 or 5 or more capsules. The most common Norwegian brand names were also 
listed.  
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A seafood index has been established and validated (Markhus et al., 2013a) for the seafood-
FFQ used in this study. In this seafood index the ordinal data with reported frequency from the 
seafood-FFQ was converted to numerical data. The basis for conversion of frequency of seafood 
consumption into a seafood index can be seen in Table 2.1. This made it possible to combine 
different types of seafood and quantity estimations of seafood consumptions into a numerical 
index.  
Seafood index was established for 5 dinner items: oily fish, lean fish, processed fish, shellfish 
and freshwater fish, as well as for total seafood spread, and total seafood supplements (including 
all omega-3 supplements). The 5 dinner indexes were summed to a total seafood dinner index. 
A total seafood index was then computed as a sum of total seafood dinner index, seafood spread 
index and supplement index.  
Table 2.1 Seafood index: The seafood index - conversion of frequencies to numerical values (Markhus et al., 2013a) 
Reported frequency Numerical interval 
per weeka 
Seafood index 
(summary question)b 
Seafood index (detailed 
item question)c 
Never 0 0 0 
<1 time/month >0-0.25 0.15 0.1d 
1-3 times/month 0.25-0.75 0.5 0.25 
1-2 times/week 1.0-2.0 1.5 1 
≥3 times/week  ≥3 3 3 
a Numerical interval based on the average weekly frequency of seafood intake for dinner and seafood intake as spread. 
b Seafood index assigned the average weekly frequency of seafood intake for dinner and seafood intake as spread. 
c Seafood index based on the lowest possible weekly intake of seafood items eaten as dinner and items eaten as spread. 
dNumerical value set to 0.1 to enable distinction between the two lowest frequencies. 
2.3.2 Infant diet 
To assess the food intake for infants, a combination of 24-hour recall interviews (3-, 6- and 12 
months) and a short interviewer administrated FFQs (6- and 12 months) were given. The same 
interviewer conducted all the interviews to get the best contingency in the dietary data.  
During the 24-hour recall interviews the mother was asked to list everything the infant had 
consumed for the last 24-hours including supplements (vitamin D, omega-3), and if breast milk, 
formula or both were given.   
The short FFQ had questions about milk (breast milk, formula, and cow’s milk), exclusive 
breastfeeding/formula, introduction to solids, frequency of cereal, dinner, bread, fruit, and 
seafood.  
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2.3.3 Blood sampling 
Non-fasting venous blood was collected from the elbow cavity of both mother and child at 3-, 
6- and 12 months postpartum as well as in 28th gestation week for the mother (Markhus et al., 
2013b). The blood was then put into a 3.5 ml BD VacutainerH SSTTM vials II Advanced for 
preparation of serum that coagulated for 30-60 minutes before centrifugation (1000×g) at 3000 
rpm for 10 minutes. The serum was transferred to plastic tubes and stored at -20°C for up to 4 
weeks before it was transported to NIFES where it was stored at - 80°C until analysis.  
2.3.4 Anthropometric data 
Age, height and weight, both before pregnancy and at current date, were included in the 
seafood-FFQ for the mothers.  
Children were weighed naked on an infant scale after birth and at health checks at 3, 6 and 12 
months (after the blood sample was taken). Head circumference and length were measured at 
birth and provided at the 3 month time point. These were also measured at 6 and 12 months. 
2.4 PCB-analysis 
The determination of PCB-concentrations in human serum is based on a liquid-liquid extraction 
method developed by Lu et al. (2012) and further quantifications by High Resolution Gas 
Chromatography-High Resolution Mass Spectroscopy (HRGC-HRMS). The low amount (20-
100 µl) of serum sample required for the PCB-analysis was considered the most attractive 
feature when selecting this particular method. The limited amount of serum from new-borns 
could be a limitation in PCB biomonitoring, hence the importance of the selected method.  
All serum samples were analysed between October 2013 and March 2014, total number of 
analysed serum samples that passed evaluation can be seen in Table 2.1. The specific 
analytical PCB-congeners assessed in this project were PCB-118 (2.3'.4.4'.5-PCB), PCB-138 
(2.2'.3.4.4'.5'-PCB), PCB-153 (2.2'.4.4'.5.5'-PCB) and PCB-180 (2.2'.3.4.4'.5.5'-PCB).  
2.4.1. Internal and recovery standards 
The internal standard (ISTD) consists of known concentrations of isotopically labelled analytes 
that is added to the serum samples to find the unknown concentrations through isotope dilution-
method (see calculation 2 and 3 in Section 2.6). A recovery standard (RSTD) is added at the 
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end of sample preparation in order to qualify the extraction process. Preparation of ISTD and 
RSTD with a chemical-list can be seen in the Appendix-2 Table A.1. 
2.4.2 Preparation of serum sample  
Randomized serum samples were thawed at room temperature before analysis, and kept at -4ºC 
in between analysis. The thawed serum samples were vortex-mixed for a few seconds before 
pipetting 100 µl of serum into to a polypropylene plastic container. Aliquots of 20 µl ISTD and 
10 µl formic acid were added and the mixture was vortex-mixed for 1 min. An aliquot of 100 
µl distilled water and 50 µl acetone was added, and the mixture was vortex-mixed for 1 min. A 
mixture of dichloromethane/isohexane 1:4 (1 ml) was added and the mixture was vortex-mixed 
for 1 min before it was centrifuged (1720×g) at 3200 rpm for 2 minutes. The upper-phase was 
collected and transferred to a plastic tube while the lower-phase was treated with 1ml isohexane, 
vortex-mixed for 1 min and centrifuged again. This lower-phase with isohexane was then placed 
in a freezer (-4ºC) for a minimum of 20 minutes. After freezing the sample was once again 
centrifuged (1720×g) at 3200 rpm for 2 minutes before the upper phase was transferred to the 
plastic tube together with the previously collected upper-phase. The tubes were placed on a 
block heater at 35ºC and nitrogen gas was used to vaporize the solution until 1 ml was left. The 
solution was then transferred to a tapered vial and vaporized to 0.5 ml. Aliquots of 10 µl RSTD 
and 30 µl of sulphuric acid were added to each sample before they were vortex-mixed for 1 
min. The sample was left to stand for 10 minutes before it was vortex-mixed for 30 sec. and 
then centrifuged (284×g) at 1300 rpm for 2 minutes. The upper phase was then transferred over 
to a tapered vial containing 20μl nonane and vaporized down to 20 μl in a ventilated hood. List 
of chemicals is presented in Appendix-2 Table A.2. 
2.4.3 High Resolution Gas Chromatography/High Resolution Mass Spectrometer 
The instrument used to determine the concentration of the various PCB-congeners was the 
Trace GC Ultra/DFS model from Thermo Fischer Scientific (Waltham, Massachusetts, USA). 
This is a High Resolution Gas Chromatography/High Resolution Mass Spectrometer 
(HRGC/HRMS). This instrument combines the separating properties of gas chromatography 
with the detection and identifying properties of the mass spectrometer (McMaster, 2007).  
The gas chromatography process starts with the injection of 1 µl of the sample through the 
injection port. The sample is heated to 300° C which turns it into a gas before it goes into the 
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30 m long capillary column (“TR-DIOXIN-5MS” Thermo) with an internal diameter of 0.25 
mm. The chromatographic column is coated with a 0.1 µm inert polymer which is the stationary 
phase. The mobile phase is the carrier gas and consists of helium. Separation of the analytes in 
the gas depends on the volatility and affinity of the analyte. The higher the volatility the easier 
the analyte moves with the carrier gas, but with greater affinity to the liquid phase the analyte 
will be retained and use longer time through the column. From the HRGC the analytes are sent 
into the HRMS for detection and identification. In the interface module before the analytes 
reach the HRMS some of the carrier gas is removed by differences in diffusion coefficients 
between the carrier gas and the analytes (McMaster, 2007). The analytes then go through the 
ionization chamber where they are pummelled with electrons to turn them into ions. These ions 
then enter the mass-analyser which contains a double focusing magnetic mass spectrometer 
(DFS).  There are two major parts to the DFS. First the ions get magnetically deflected in the 
magnetic section before they enter the electrostatic sector where they are focused before they 
enter the detector (Holcapek, 2014). In the detector the ions get amplified when they hit the first 
wall. When the ions hit the wall they cause a cascade of electrons that again will start a new 
cascade as they hit the next wall in the same detector (McMaster, 2007). When this current of 
electrons gets big enough it can be measured, and the information is sent to a computer where 
a mass spectrum chromatogram is created. The size of the current is dependent on the amount 
of ions that hits the detector wall in the first place (McMaster, 2007).The instrument generates 
a mass chromatogram and traditional chromatograms. The former is a representation of the 
signal strength against the mass/charge ratio and it is generally known as total ion 
chromatogram (TIC, Figure 2.1), whereas the latter shows the classical signal against time. The 
chromatograms are created by the Xcalibur / TargetQuan software Version 2.0, 1998-2005. 
 
Figure 2.1 Total ion chromatogram of the certified reference material: with PCB-111 (recovery standard), 
PCB-118, PCB-138 and PCB-153 marked at their chromatogram peak 
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2.5 Practice in the laboratory 
Due to risk of exposure of pathogens, special precaution has to be taken when dealing with 
human samples. All human samples that are collected by NIFES are risk evaluated by the 
infection/disease control group before analysis. The people working with human samples 
undergo theoretical and practical training given by the infection/disease group before they are 
authorized to work with human samples, as well as offered vaccination against hepatitis A and 
B. 
2.6 Calculations  
Body mass index (BMI) was calculated on the basis of height and weight information self-
reported in the seafood-FFQ (1).  
𝐵𝑀𝐼 =
𝑤𝑒𝑖𝑔ℎ𝑡 (𝑘𝑔)
ℎ𝑒𝑖𝑔ℎ𝑡2 (𝑚2)
         (1) 
Concentrations of PCBs (3) in each serum sample was assessed by isotope dilution and 
calculated by using the relative response factor (RR) (2) which is the ratio of the slope and were 
determined from the calibration curve. RR compensates for differences in instrument response 
and analytical gain. ISTD and PCB are denoted by the subscripted ISTD and PCB.  
𝑅𝑅 =  
𝐴PCB 𝑥 𝐶𝐼𝑆𝑇𝐷
𝐴𝐼𝑆𝑇𝐷 𝑥 𝐶PCB
               (2) 
𝐶PCB = (
(𝐴𝑃𝐶𝐵 𝑥 𝐴𝐼𝑆𝑇𝐷 𝑥 𝑀𝐼𝑆𝑇𝐷)
𝑅𝑅
)/𝑉(𝑚𝑙)                                            (3)  
K = slopes, A= area under peak, C= concentration, M= mass of ISTD, V= volume of sample   
To find the effect size (r) from the Mann-Whitney test, formula (4) is used.  
𝑟 =
𝑧
√n
                                                                                                     (4) 
r= effect size, z= standard score, n= number of observations 
Cohen’s rule of thumb was used to determine the effect size: r=0.10 equals a small effect, r=0.30 
is a medium effect and r=0.50 is considered a large effect (Fiels, 2013). 
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2.7 Method evaluation 
Since this is a new method different validation parameters were considered to evaluate the 
correct application of the analytical method. The parameters evaluated in this project were: 
selectivity, accuracy, precision, recovery, sensitivity and limit of quantification (LOQ). 
Selectivity defines the ability of an analytical method to quantify and separate the analyte from 
the other sample components (Huber, 2010). This can be evaluated by analysing blank samples 
of an appropriate matrix and testing it for interference with the analyte. In this project distilled 
water samples were analysed to ensure that the 100 µl of added distilled water did not interfere 
with the PCB-concentrations in the serum samples (Appendix 4: Figure A.8-A.11). The blank 
water samples was not retracted from the PCB-concentrations in the serum samples. This was 
done to give an indication of the uncertainty in the method, and will probably be a part of the 
uncertainty-calculations when the method is validated. 
Accuracy describes how close the mean test results are to the true concentration of the analyte. 
Precision describes the closeness between individual measurements of an analyte (degree of 
scatter). The precision of a method also includes reproducibility of the analysis, which can 
involve different analysts and precision over time (Huber, 2010). Serum Certified Reference 
Material (SRM 1957, National Institute of Standards and Technology, Gaithersburg, US) was 
used to check the accuracy and precision of the method (Appendix 4: Figure A.4-A.7).  
Recovery of an analyte is the detector response from the internal standard and recovery standard 
compared to the extraction of the analyte in the sample. Although the recovery of a particular 
method need not be 100%, its range of variation should be specified in advance. For example, 
in the present project the recovery is set between 30-130%. The selected recovery range is based 
on previous results from contaminant analyses which were relatively robust inside this range.  
Sensitivity is the lowest analytical value that a particular method is able to detect. To establish 
the sensitivity of a method a calibration standard curve between instrument response and known 
concentrations of the analytes should be made. The lowest standard on this curve should be 
accepted as the lower limit of quantification (LOQ). The calibration standards are solutions 
with known concentrations of the different analytes. Considering that the analytical method 
used in the present project has not been validated yet, preliminary LOQ-values (Table 2.2) were 
established based on previous results during method development. It is important to mention 
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that values below the LOQ levels are referred in the present project as limit of detection values 
(LOD). A LOD value suggests that the analyte was detected, but its associated uncertainty is 
too high to be considered quantitatively reliable. Therefore the values under LOQ were set to 
the LOQ-value. This is an example of “upper bound” limit, used to not underestimate the PCB-
concentration (FAO/WHO, 2012). Most values under LOQ were just below the LOQ, which 
suggests that the value was detectable, but the uncertainty around this value is too high to be 
considered quantitative. 
Table 2.2 Limit of quantification (LOQ) values for PCB-118, -138, -153 and -180. 
Analyt PCB-118 PCB- 138 PCB-153 PCB-180 
LOQ (ng/ml) 0.01 0.009 0.02 0.01 
Mean values are reported for serum samples analysed in duplicate. A particular standard 
(Standard 3) with a known concentration (Appendix 2: Table A.3) was consistently used 
throughout the HRGC-HRMS analysis to confirm the validity of the calibration curve and 
consequently the reliability of the computed concentrations at specific days (control card in 
Appendix 4, Figure A.12 to A.15). Standard 3 is the third standard used in the calibration 
standard curve of the instrument.  
The analysed samples were also excluded if the chromatogram showed abnormal elution of 
compounds of interest. The areal of the peak was then not possible to calculate.  
Table 2.3 shows the dietary data collected for mothers and children, as well as the number of 
serum samples for mothers and children that passed evaluation, and are used in this project. 
Table 2.3 Dietary data and analysed serum samples: Listed are number of serum samples analysed for PCB-
118, -138, -153, -180  that passed evaluation in this project for mothers at 28th week in pregnancy and for mothers 
and children at 3-, 6-, and 12 months postpartum. As well as number of Seafood-FFQs collected from mothers, 
and 24 hour recall interview (3 months), and short FFQs completed for the children in this study population at 3-, 
6- and 12 months postpartum 
 
28th week in 
pregnancy 
3 months 
postpartum 
6 months 
postpartum 
12 months 
postpartum 
Serum samples mothers 61 82 85 73 
Seafood-FFQ mothers 55 92 87 82 
Serum samples children - 47 61 52 
24h or FFQ children - 97 94 83 
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2.8 Statistical analysis 
All statistical analyses were carried out using IBM Statistical Package for the Social Sciences 
(SPSS) Statistics 21 or GraphPad Prism 6.  
Figures and tables were made using IBM SPSS Statistics 21, GraphPad Prism 6 or Microsoft 
Office Excel 2013. 
Outliers were examined with “Robust regression and Outlier removal”-test (ROUT-test) and 
scatterplots. There was little difference in mean and median with and without ROUT-test 
(Appendix 3: Figure A.2 and Table A.5). It is normal to have some biological variations in a 
population, with some subjects at higher or lower values than others; therefore all the values 
were used in this project.  
Normality was tested with the parametric Shapiro-Wilk test and the non-parametric 
Kolmogorov-Smirnov test. Distribution was examined with scatterplots and histograms. 
Dietary seafood intake and PCB-concentrations were not normally distributed, except for total 
seafood consumption and CRM. These two were therefore analysed with one-way ANOVA 
(total seafood over time) and t-test (CRM). Non-parametric tests were used for all other 
statistical analysis and median is therefore used, instead of mean, when non-parametric tests 
are used.  
The results are presented as mean ± standard deviation (SD) and median ± interquartile range 
(IR). Where appropriate, minimum and maximum values are also provided. Number of 
significant digits in mean and median values varies according to the SD or IR.  
Differences between groups were examined using either the two-sided non-parametric Mann-
Whitney U test to look at difference in distribution, or the Kruskal-Wallis test to look at 
differences in median. Spearman Rank Correlation was used to examine bivariate and partial 
associations. Friedman two-way test and Wilcoxon Signed Rank test was used to detect 
differences across several sample concentrations. Pairwise comparison followed Friedman two-
way test in those cases where there was a significant difference.  
A p-value below 0.05 was used as statistical value of significance in all the tests, whereas a p-
value around 0.1 indicates a trend.  
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3. Results 
3.1 Descriptive characteristics of the study population 
 
Figure 3.1 Flowchart of study population and collected data: Number (n) of blood samples and dietary data from mothers 
and children at 28th week in gestation, 3-, 6- and 12 months after birth. Dietary data is reported in seafood-FFQ (S-FFQ) for 
the mothers, and as 24hour (24h) recall interview (3 months) and short FFQ (6- and 12 months).  
Of the 128 women recruited in this study, 70 were enrolled in pregnancy and 58 after birth, but 
before 3 months postpartum (Figure 3.1). There were 27 women and 20 children that had a 
complete longitudinal dataset with seafood-FFQ and serum samples analysed for PCBs at all 
the time points.  
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The characteristics of all the mothers that answered seafood-FFQs at the different time-points 
are summarised in Table 3.1.  
The mothers had a significantly higher body mass index (BMI) at 3- and 6 months after birth 
than before pregnancy (3 months: p<0.001, χ2(1)=-1.294, n=34, 6 months: p=0.039, χ2(1)=-
0.853, n=34). However, there was no difference at 12 months compared to pre-pregnancy 
weight. The focus on eating healthy in this study population was reflected in 62% reporting a 
high or very high focus level on having a healthy diet during the pregnancy. After birth (3 
months) this high focus on a healthy diet had declined to 53%. 
In this study population, between 61- and 71% were educated at a university or university 
college. This degree of higher education was also evident in the income of this group with more 
than 70% of the expecting mothers earning over 300 000 Norwegian kroner/year, and over 20% 
earning more than 400 000 Norwegian kroner/year. Among the partners/husbands over 70% 
earned more than 400 000 Norwegian kroner/year. 
The children had the same mean weight and length at birth at each time-point (Table 3.2). The 
distribution of sexes were also fairly constant with a slightly higher number of boys (54-57%). 
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Table 3.1 Mothers characteristics: Characteristics for mothers’ that answered the Seafood-FFQ at 28th gestation week and 
3-, 6- and 12 months postpartum with mean,  standard deviation (SD), minimum (min), maximum (max) and number of mothers 
(n). 
Characteristics 28th gestation 
week 
3 months 6 months 12 months 
n 55 92 87 82 
     
 Mean ± SD   
(min, max) 
Mean ±  SD     
(min, max) 
Mean ±  SD  
(min, max) 
Mean ±  SD  
(min, max) 
Age (years) 30 ± 5 (19, 41) 30 ± 5 (19,42) 31 ± 5 (19,42) 32 ± 5 (20,42) 
Current weight (kg) 76 ± 11 (55, 102) 71 ± 13 (51,109) 70 ± 13 (49,117) 69 ± 13 (48,110) 
Pre-pregnancy weight 
(kg) 
67 ± 11 (47,95)    
Height (cm) 168 ± 7 (152,180) 169 ± 6 (152,180) 168 ± 7 (152,180) 168 ± 7 
(153,181) 
BMI (kg/m2) 24 ± 4 (17,35) a 25 ± 5 (17,43)* 25± 4 (17,40)* 24 ± 4 (16,37) 
     
 Count n (%) Count n (%) Count n (%) Count n (%) 
BMI category a     
Severely underweight 
(<16) 
0 (0) 0 (0) 0 (0) 0 (0) 
Underweight (16-18.49) 3 (6) 2 (2) 2 (2) 3 (4) 
Normal (18.5-24.99) 32 (59) 46 (52) 43 (51) 43 (52) 
Overweight (25-29.99) 15 (28) 27 (30) 31 (36) 30 (37) 
Obese class 1 (30-34.99) 3 (6) 10 (11) 7 (8) 4 (5) 
Obese class 2 (35-40) 1 (2) 3 (3) 2 (2) 2 (2) 
Obese class 3 (>40) 0 (0) 1 (1) 0 (0) 0 (0) 
Education     
 Lower secondary school 0 (0) 4 (4) 5 (6) 6 (7) 
Higher secondary school 16 (29) 28 (30) 29 (33) 25 (30) 
< 4 years of universityb 24 (44) 34 (37) 37 (43) 39 (48) 
> 4 years of universityb 15 (27) 26 (28) 16 (18) 12 (15) 
Self-reported 
smoking/snuff 
1 (2) 7 (8) 7 (8) 11 (13) 
Exercise     
Never 1 (2) 2 (2) 4 (5) 2 (2) 
<1 time/week 5 (9) 6 (7) 5 (6) 9 (11) 
1 time/week 13 (24) 13 (14) 3 (3) 11 (13) 
2-3 time/week 26 (47) 27 (29) 33 (38) 30 (37) 
4-6 time/week 7 (13) 30 (33) 27 (31) 21 (26) 
Every day 3 (5) 14 (15) 15 (17) 9 (11) 
Focus on a healthy diet     
Small 3 (5) 3 (3) 4 (5) 3 (4) 
Medium 18 (33) 40 (43) 41 (47) 37 (45) 
High  32 (58) 44 (48) 36 (41) 35 (43) 
Very high 2 (4) 5 (5) 6 (7) 7 (8) 
Caucasian descent 52 (95) 89 (97) 83 (95) 76 (93) 
Primiparousc 51 (49%) 
a BMI and the BMI category for 28 weeks is based on weight before pregnancy  
b University or University College 
b Primiparous: first pregnancy. This was the combined answer from question on previous children from all seafood-FFQs; 
some did not answer this question when they had answered it in a previous seafood-FFQ   
*BMI significantly higher than at 28th week in gestation 
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Table 3.2 The children’s characteristics: Characteristic for children with answered 24hour recall interview or 
short FFQ at 3-, 6- and 12 months after birth, with number of children (n), mean, standard deviation (SD) and 
minimum (min) and maximum (max) values   
Characteristics 3 months 6 months 12 months 
n 97 94 83 
    
 Count n (%) Count n (%) Count n (%) 
Sex    
Girls 44 (46) 42 (45) 36 (43) 
Boys 52 (54) 52 (55) 47 (57) 
Not reported 1 0 0 
    
Twin pairs, n 2 2 2 
    
 Mean ±  SD (min. max) Mean ±  SD (min. max) Mean ±  SD (min. max) 
Birth week 40 ± 2 (34, 42) 40 ± 2 (34, 42) 40 ± 2 (36, 42) 
Weight at birth (g) 3558 ± 645 (1610, 5140) 3558 ± 645 (1610, 5140) 3558 ± 626 (1640, 5140) 
Length at birth (cm) 51 ± 3 (43, 57) 51 ± 3 (43, 57) 51 ± 3 (43, 57) 
Current weight (g) 6353 ± 830 (4470, 9000) 8106 ± 935 (6250, 11500) 100057 ± 1170 (7900, 
13500) 
Current length (cm) 62 ± 3 (53, 68) 68 ± 3 (57, 75) 77 ± 3 (68, 85) 
 
3.2 Maternal seafood intake 
Estimations of seafood consumption in grams per week were based on the seafood index for 
the different seafood products and the specified portion sizes (Table 3.3). There was also a 
question concerning total seafood as dinner, and the estimated median per week there was 225 
g, which was consistent over the four time points.  
No difference was found between total seafood (dinner, spread and supplement) consumed at 
the different time points using the seafood index. There was also no difference in seafood intake 
as dinner, seafood as spread, supplement intake, shellfish, lean fish, roe liver pate (Svolvær or 
Lofoten), or processed fish. The only category that was significantly different over the time 
points was oily fish (p=0.017, n=37, χ2(3)=10.16) with a higher consume at 6- and 12 months 
than at 28th week in gestation.  
These was no significant differences in the estimated weekly intake of seafood as dinner, 
spread, oily, lean, processed or shellfish between those that exclusively breastfed and those that 
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did not breastfeed, except for a higher lean fish consumption at 3 months for non-breastfeeding 
mothers (p=0.013, r=0.27, ntotal=84, nnon-breastfeeding=15)  
Table 3.3 Seafood consumption: Estimated consumption of seafood as grams (g) per week at 28th week in 
gestation and at 3-, 6- and 12 months after birth. Estimated from median index intake for each seafood category at 
the different time-points.   
Seafood category 28 weeks 3 months 6 months 12 months 
  g/week (%) g/week (%) g/week (%) g/week (%) 
Oily 53 (22) 56 (22) 83 (28) 79 (26) 
Lean 79 (33) 75 (29) 83 (28) 90 (29) 
Processed 79 (33) 94 (36) 90 (30) 90 (29) 
Shellfish 32 (13) 34 (13) 45 (15) 49 (16) 
Total 243 (100) 259 (100) 301 (100) 308 (100) 
 
All the women in the study population consumed seafood for dinner at least once during the 
last three months (Figure 3.2). The majority of the mothers consumed seafood for dinner 1-2 
times per week. During pregnancy 71% of the participants had seafood for dinner 1-2 times per 
week, but only 4% had it 3 or more times per week. Postpartum only 59-60% of the participants 
had seafood 1-2 times per week, but 12-15% reported consuming fish 3 or more times per week 
at these stages.  
 
 
Figure 3.2 Seafood as dinner: Frequency of seafood as dinner for mothers at 28th week in gestation and 3, 6 and 
12 months postpartum. 
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There was little difference in the prevalence of frequencies over time for seafood as spread 
(Figure 3.3). There was a tendency (p= 0.074, χ2(3)=6.94, n=36) towards increased 
consumption of spread per week, when looking at the seafood index, from in pregnancy to 12 
months postpartum. Over 70% of the participants consistently reported consuming an oily type 
of seafood as spread (mackerel, herring or salmon) while the remaining 30% only ate the lean 
type (shrimps, fishcakes).    
 
Figure 3.3 Seafood as spread: Frequency of consumption of seafood as spread for mothers at 28th week gestation 
and at 3, 6 and 12 months postpartum. 
At 28th week in pregnancy, 63% of the women reported consuming omega-3 supplements more 
than 4 times per week. At 3 months after birth, 74% reported using omega-3 supplements more 
than 4 times per week. After 12 months the omega-3 supplement intake had declined to 44% 
taking it more than 4 times per week. 
There was a significant correlation (p < 0.05) between seafood as dinner, total seafood (dinner, 
spread and supplement) and intake of salmon/trout for dinner against reported focus on a 
healthy lifestyle in pregnancy (Appendix 3: Table A.4). At 3 months a healthy lifestyle was 
again correlated with seafood as dinner and total seafood intake, which include omega-3 
supplement, but not with salmon/trout for dinner. Instead it was now also correlated with intake 
of cod for dinner, supplement intake and seafood as spread intake. At 6 months it was only 
salmon/trout for dinner that was correlated with focus on a healthy lifestyle, and at 12 months 
there was no correlation between any seafood and focus on a healthy lifestyle.  
Fish liver was consumed on a yearly basis by 16 mothers in the study population. Roe liver pate 
consumption was low, peak consumption occurred 12 months after birth, and was then 
consumed by 7 mothers. 
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3.3 Children’s dietary habits  
At 3- and 6 months the majority of the children were not given omega-3 supplements. However, 
at 12 months over 50% received omega-3 supplements and 37% received omega-3 supplements 
more than 4 times per week. Between 40 - 50% of the breastfed children got omega-3 
supplements at 3- and 6 months, while among the non-breastfed the prevalence was below 40%.  
Breastfeeding prevalence decreased from 64% fully breastfed at 3 months to 7% at 6 months, 
whereas 70% and 33% were still breastfeeding daily at 6 and 12 months respectively (Table 
3.4). At 6 months 88% had started introducing other foods than formula or breast milk. Of 
particular interest, seafood as dinner was consumed by 15% of the children at 6 months and 
89% at 12 months.   
 
Table 3.4 The children’s eating habits: at 3-, 6- and 12 months after birth with number of children (n) 
Nutrition 3 months 6 months 12 months 
  Total n =97 Total n =94 Total n =83 
 n (%) n (%) n (%) 
Exclusively breastfed 62 (64) 7 (7) - 
Breastfed daily 79 (81) 66 (70) 27 (33) 
Not breastfed 18 (19) 28 (30) 56 (67) 
Formula 35 (36) 54 (57) 37 (46) 
Porridge - 83 (88) 74 (90) 
Othera - 58 (62) 81 (99) 
Seafoodb - 14 (15) 74 (89) 
aFruit, bread and dinner 
 bSeafood as dinner 
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3.4 Serum PCB-concentrations 
The mean and median of PCB-118, -138, -153 and -180 in ng/ml serum from mother and child 
are listed in Table 3.5. PCB-118 was at the most modest levels, which is reflected by several 
observations below LOQ. PCB-153 was found to be the most prominent congener, although 
several values were also here found to be below LOQ. PCB-138 and -180 appears to accumulate 
at the same levels, and also have fewer values below LOQ than PCB-118 and PCB-153.   
 
Table 3.5 Descriptive of PCBs: Descriptive serum PCB-118, -138, -153, -180 and sum PCB (138+153+180) 
(Sum PCB) concentrations in mothers at 28th week in gestation and for mothers and children at 3-, 6-, and 12 
months, with number of participants (n), mean value in ng/ml serum, standard deviation (SD), median in ng/ml 
serum, interquartile range (IR), maximum (Max) and minimum (Min) concentrations 
  n Mean (ng/ml) SD Median (ng/ml) IR Max Min 
PCB 118              
Mother 28 weeks 61 0.03 0.02 0.03 0.02 0.13 1<LOQ 
Mother 3 months 82 0.02 0.02 0.02 0.01 0.13 12<LOQ 
Mother 6 months 85 0.02 0.02 0.02 0.02 0.16 14<LOQ 
Mother 12 months 73 0.02 0.01 0.02 0.02 0.07 16<LOQ 
Child 3 months 47 0.03 0.02 0.03 0.02 0.08 6<LOQ 
Child 6 months 61 0.03 0.02 0.03 0.02 0.1 8<LOQ 
Child 12 months 52 0.03 0.02 0.03 0.03 0.07 5<LOQ 
PCB 138              
Mother 28 weeks 61 0.08 0.06 0.07 0.06 0.41 0.015 
Mother 3 months 82 0.06 0.06 0.04 0.04 0.42 0.009 
Mother 6 months 85 0.06 0.07 0.05 0.03 0.55 0.009 
Mother 12 months 73 0.06 0.04 0.05 0.04 0.21 0.01 
Child 3 months 47 0.08 0.06 0.06 0.08 0.29 1<LOQ 
Child 6 months 61 0.07 0.06 0.05 0.07 0.34 1<LOQ 
Child 12 months 52 0.08 0.09 0.06 0.08 0.55 1<LOQ 
PCB 153              
Mother 28 weeks 61 0.14 0.08 0.13 0.07 0.52 0.02 
Mother 3 months 82 0.09 0.06 0.08 0.06 0.48 2<LOQ 
Mother 6 months 85 0.10 0.09 0.08 0.06 0.7 3<LOQ 
Mother 12 months 73 0.10 0.07 0.08 0.06 0.34 2<LOQ 
Child 3 months 47 0.12 0.09 0.1 0.1 0.36 2<LOQ 
Child 6 months 61 0.12 0.09 0.1 0.1 0.44 5<LOQ 
Child 12 months 52 0.1 0.1 0.1 0.1 0.41 4<LOQ 
PCB 180              
Mother 28 weeks 61 0.09 0.05 0.08 0.06 0.23 0.01 
Mother 3 months 82 0.07 0.05 0.06 0.04 0.33 0.01 
Mother 6 months 85 0.07 0.05 0.06 0.05 0.31 0.02 
Mother 12 months 73 0.07 0.06 0.06 0.04 0.35 1<LOQ 
Child 3 months 47 0.07 0.05 0.06 0.07 0.28 2<LOQ 
Child 6 months 61 0.08 0.06 0.07 0.09 0.26 5<LOQ 
Child 12 months 52 0.1 0.1 0.1 0.1 0.75 3<LOQ 
Sum PCB         
Mother 28 weeks 61 0.3 0.18 0.3 0.2 1.15 0.08 
Mother 3 months 82 0.2 0.15 0.2 0.1 1.11 0.06 
Mother 6 months 85 0.2 0.19 0.2 0.1 1.56 0.06 
Mother 12 months 73 0.2 0.14 0.2 0.1 0.69 0.06 
Child 3 months 47 0.3 0.19 0.3 0.3 0.90 0.04 
Child 6 months 61 0.3 0.20 0.3 0.3 0.99 0.04 
Child 12 months 52 0.3 0.27 0.3 0.3 1.72 0.04 
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To simplify the comparison between the different PCB-congeners, and between mother and 
child, the median is visualised in Figure 3.4, and Figure 3.5.  
 
  
 
 
The decrease of PCB-concentrations during pregnancy and postpartum is reflected in the 
increasing number of samples below LOQ (Table 3.5, Appendix 3: Figure A.2 and Figure 
A.3). 
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Figure 3.4 Mothers’ PCB medians: Mothers median concentration in ng/ml serum for the PCB-118,-138,-
153, and -180 at 28th week in gestation and at 3-, 6- and 12 months after birth 
Figure 3.5 Children’s PCB medians: Children’s median concentration in ng/ml serum for PCB-118, 
138, 153, and -180 at 3-, 6- and 12- months after birth 
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3.4.1 Seafood intake and serum PCB-levels 
Mothers (n=16) who reported consuming fish liver had higher serum PCB-levels compared to 
those not consuming fish liver at any time-point. Transfer of more PCBs from mothers who 
consumed fish liver to child was evident for PCB-138 at 3 months only (Table 3.6).  
 
Table 3.6 Fish liver consumer statistics: Mann-Whitney-test statistics for significant different distributions of 
PCB-118, -138, -153, and -180 at 28 week (w) in gestation and 3-, 6- and 12 months (m) after birth with probability 
(p), effect size (r), number (n) of mothers (M), or children (C), and median with interquartile range (IR) in ng/ml 
serum for mothers consuming liver or not consuming liver. 
 p r ntotal      
(nconsumed liver/ 
nnot consumed liver) 
Liver consumers:  
Median (ng/ml) ± IR 
Not liver consumers  
Median (ng/ml) ± IR 
Consumes liver every year   
PCB-118 M28w 0.014 0.3 61 (7/54) 0.03 ± 0.02 0.02 ± 0.01 
PCB-138 M28w 0.012 0.3 61 (7/54) 0.1 ± 0.1 0.06 ± 0.06 
PCB-153 M28w 0.002 0.4 61 (7/54) 0.2 ± 0.1 0.12 ± 0.08 
PCB-180 M28w 0.006 0.3 61 (7/54) 0.1 ± 0.05 0.08 ± 0.06 
PCB-118 M3m 0.001 0.4 82 (9/73) 0.03 ± 0.02 0.018 ± 0.009 
PCB-138 M3m 0.010 0.3 82 (9/73) 0.07 ± 0.1 0.04 ± 0.04 
PCB-153 M3m 0.005 0.3 82 (9/73) 0.13 ± 0.09 0.08 ± 0.05 
PCB-180 M3m 0.012 0.3 82 (9/73) 0.09 ± 0.05 0.06 ± 0.04 
PCB-118 M6m 0.026 0.2 85 (14/71) 0.03 ± 0.02 0.02 ± 0.01 
PCB-138 M6m 0.019 0.3 85 (14/71) 0.07 ± 0.08 0.04 ± 0.03 
PCB-153 M6m 0.003 0.3 85 (14/71) 0.1 ± 0.1 0.08 ± 0.06 
PCB-180 M6m 0.001 0.4 85 (14/71) 0.1 ± 0.07 0.05 ± 0.04 
PCB-118 M12m 0.005 0.3 73 (12/61) 0.03 ± 0.03 0.02 ± 0.01 
PCB-138 M12m <0.001 0.4 73 (12/61) 0.1 ± 0.07 0.04 ± 0.04 
PCB-153 M12m 0.003 0.3 73 (12/61) 0.2 ± 0.2 0.07 ± 0.05 
PCB-180 M12m <0.001 0.4 73 (12/61) 0.1 ± 0.1 0.05 ± 0.04 
PCB-138 C3m 0.026 0.3 47 (6/41) 0.1 ± 0.1 0.06 ± 0.06 
At 12 months there were 7 mothers that reported consuming roe liver pate, but there were no 
significant differences between these 7 participants and the rest of the mothers at 12 months.  
There were no significant differences in serum concentrations of PCBs for those who ate more 
or less than 300 g of total seafood for dinner per week, nor between those that ate more or less 
than 450 g of total seafood per week, at any of the time points. 
For oily fish there was no significant difference between those who consumed more or less than 
200 g. For those who consumed more or less than 300 g there was only a significant difference 
between PCB-180 for mothers at 6 months (p =0.042, r= 0.23, nunder300g= 71, nover300g=7), with 
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higher serum concentration among oily fish consumers. When dividing the study population 
into breastfeeding or non-breastfeeding, this difference for oily fish was found only among 
those that did not breastfeed (p =0.027, r=0.25, nunder300g= 22, nover300g=3). Of the 7 consuming 
more than 300 g of oily fish 2 were also fish liver consumers. When fish liver consumers were 
removed from the dataset the significant difference for PCB-180 at 6 months between mothers 
who consumed more or less than 300 g of oily fish disappeared.  
Shellfish consumption was the only significant correlation found between seafood and serum 
levels of PCBs in pregnancy, and only for PCB-153 (p=0.040, n=48) and PCB-180 (p=0.044, 
n=48) (Table 3.7). When considering the higher endogenous exposure these women get from 
losing weight after the pregnancy, as well as the PCBs they might lose through breastfeeding, 
correlations after birth were considered unreliable and were therefore omitted. 
Table 3.7 Seafood correlation: Spearman’s correlation coefficient (ρ) for different categories of seafood intake 
against PCB-118, -138, -138, -180 for week 28 in pregnancy. 
 PCB-118 PCB-138 PCB-153 PCB-180 
Seafood for dinner     
Total -.014 -.074 -.177 .018 
Oily fish .246 -.002 -.052 -.019 
Lean fish .053 .255 -.071 -.117 
Shellfish -.002 .217 .297* .292* 
Processed .228 -.032 -.009 -.118 
Lofoten (roepate) .037 .016 -.089 -.132 
Seafood spread -.021 -.027 .051 -.054 
Supplement -.096 -.044 -.130 -.128 
Total seafood -.125 -.001 -.077 -.033 
Total seafood: dinner index +spread index +supplement index                                                 *Significant difference: p<0.05 
Supplement: cod liver oil, omega-3 supplement                                            
Lean fish: Lean and intermediate oily fish 
Oily fish: fish with more than 5g of fat per 100g of fish 
When removing the fish liver consumers from the study population (now n=41) the correlation 
between shellfish and PCB-153 and -180 disappeared.  
No significant difference was found for PCB-levels at 12 months for those children that had 
started eating seafood, or oily fish, for dinner compared to those who did not.  
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3.4.2 Longitudinal difference in serum PCB-levels  
There was longitudinal data from 27 mothers and 20 children. These 27 mothers and 20 children 
did not differ from the total group of mothers and children in serum PCB-levels.  
In a longitudinal perspective there was a significant difference between the levels of PCB-118, 
PCB-153 and PCB-180 at the different time points for the mothers (Appendix 3: Table A.6). 
PCB-153 decreased already at 3 months when compared to the level at 28th week in pregnancy, 
whereas a reduction in PCB-118 and PCB-180 were prominent at 6- and 12 months when 
compared to levels at 28th week in pregnancy (Appendix 3: Table A.6).  
There were no differences between the levels for any of the PCBs for the children. When 
splitting the children into breastfed and not breastfed, the only difference between time-points 
was for PCB-153 at 12 months for children breastfed for 3 months (p=0.005, χ2(2)=6.00, n=13), 
this difference was not found with daily breastfeeding for 6- or 12 months.    
3.4.3 Differences between serum PCB-concentrations in mother and child 
The median serum levels of PCB-118, -138 and -153 were higher in children compared to 
mothers at 3- and 6 months (Appendix 3: Table A.7, descriptive summary statistics of the data 
are presented in Table 3.5).  
No difference was found for distribution or median for serum concentration of PCB-180 at any 
time-point, or for any of the PCBs at 12 months after birth between mother and children.  
3.4.4 Correlation between mother and child 
There was a significant positive correlation (Figure 3.6 and 3.7) between all the serum 
concentrations for PCBs in mother and child at 3 months. PCB-180 had the strongest correlation 
with a 19.5% shared variance. PCB-180 was also the only PCB that had a significant correlation 
at 6 months postpartum. At 12 months there were no significant correlations between the serum 
PCB-concentrations in mother and child.  
To control for biased correlation, the dataset was tested without the highest values. Even 
without these values the correlations were significant.  
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Figure 3.6 Mother correlated against child 1: Correlation between mother and child for serum concentrations 
of PCB-118 and PCB-138 at 3-, 6- and 12 months (m) with number of mother-child pair (n), Spearman’s rho (ρ) 
and probability (p). 
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Figure 3.7 Mother correlated against child 2: Correlation between mother and child for serum concentrations 
of PCB-153 and PCB-180 at 3-, 6- and 12 months (m) with number of mother-child pair (n), Spearman’s rho (ρ) 
and probability (p). 
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3.4.5 BMI and age 
There were no difference between serum PCB-concentrations at 28th week in gestation for 
mothers that were overweight (BMI ≥ 25) compared to mothers that were not. 
There was a significant difference in the distributions of serum concentrations of PCB-118, -
153, -180 and sum PCB (138+153+180) between mothers over and under 30 years of age, with 
mothers over 30 years of age having the highest concentrations at 28th week in gestation (Table 
3.8 and Table 3.9). At 3 months PCB-138, -153, -180, and sum PCB (138+153+180) were 
significantly higher among mothers over 30. Serum concentration of PCB-180 was the only 
PCB that showed a difference at 6 months. At 12 months there were no differences in PCB-
concentrations between the age groups.  
Since 11 of the 16 liver consumers were over 30 years of age, and 4 more where 28 or 29, the 
age differences in PCB-concentrations where examined again without these 16 women. The 
same significant age differences appeared with or without these mothers. 
 
Table 3.8 Age-difference statistics: Mann-Whitney test statistic for significant different distributions of PCB-
118, -138, -153 and -180 at 28th week (w) in gestation, and 3-, and 6 months (m) after birth with probability (p), 
effect size (r), and number of mothers (n) for mothers over or under 30 years of age. 
PCB-congener p r n (nover 30/nunder 30) 
PCB-118 28w 0.007 0.4 49 (24/25) 
PCB-153 28w 0.05 0.3 49 (24/25) 
PCB-180 28w 0.012 0.4 49 (24/25) 
sum PCB (138+153+180) 28w 0.036 0.3 49 (24/25) 
PCB-138 3m 0.031 0.3 72 (43/29) 
PCB-153 3m 0.009 0.3 72 (43/29) 
PCB-180 3m 0.001 0.4 72 (43/29) 
sum PCB (138+153+180) 3m 0.002 0.3 72 (43/29) 
PCB-180 6m 0.033 0.2 78 (50/28) 
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Table 3.9 Serum PCB-medians for mothers over and under 30 years of age:  Median concentrations with 
interquartile range (IR) in ng/ml for PCB-118, -138, -153, -180 and sum PCB (138 + 153 + 180) in serum for 
mothers divided into under and over 30 years of age at 28th week (w) in pregnancy and 3-, 6-, and 12 months (m) 
postpartum  
Time-
point 
Age PCB-118  
(ng/ml) 
Median ± IR 
PCB-138 
(ng/ml) 
Median ± IR 
PCB-153 
(ng/ml) 
Median ± IR 
PCB-180  
(ng/ml) 
Median ± IR 
Sum PCB 
138+153+180 
(ng/ml) 
Median ± IR 
28w 
 
19-29 0.02 ± 0.01 0.07 ± 0.07 0.13 ± 0.07 0.08 ± 0.06 0.3 ± 0.2 
30-41 0.03 ± 0.02 0.07 ± 0.07 0.16 ± 0.07 0.11 ± 0.06 0.3 ± 0.2 
3m 
 
19-29 0.02 ±  0.01 0.03 ± 0.04 0.07 ± 0.03 0.05 ± 0.03 0.2 ± 0.1 
30-41 0.02 ± 0.2 0.05 ± 0.05 0.09 ± 0.06 0.07 ± 0.05 0.2 ± 0.2 
6m 
 
19-29 0.02 ± 0.01 0.04 ± 0.04 0.08 ± 0.05 0.05 ± 0.04 0.2 ± 0.1 
30-42 0.02 ± 0.02 0.05 ± 0.04 0.10 ± 0.07 0.07 ± 0.05 0.2 ± 0.2 
12m 
 
19-29 0.02 ± 0.02 0.05 ± 0.06 0.08 ± 0.06 0.05 ± 0.05 0.2 ± 0.2 
30-42 0.02 ± 0.02 0.05 ± 0.04 0.08 ± 0.05 0.06 ± 0.04 0.2 ± 0.1 
 
When the study population was separated into breastfeeding or not breastfeeding it became 
evident that the age dependent differences on serum PCB-levels were only present in mothers 
that did not breastfeed (Table 3.10). Mothers that did not breastfeed had significantly higher 
serum PCB-concentrations at 3- and 6 months for those over 30 years of age, except for PCB-
118 at 6 months. At 12 months only serum concentration of PCB-180 was higher among 
mothers over 30 years that did not breastfeed, but at this time-point many of the non-
breastfeeding mothers had stopped breastfeeding only a few months earlier. When testing for 
mothers that did not breastfeed at 6 months against serum PCB-concentrations at 12 months, 
there was still a PCB-difference, for all the PCBs, between over and under 30 years of age.  
For mothers that breastfed the only exception was serum concentration of PCB-180 at 3 months, 
which was still higher among those that were over 30.    
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Table 3.10 Effect of breastfeeding on mothers over and under 30 years of age: Mann-Whitney test statistic for 
significant different distributions of PCB-118,-138,-153, -180 and sum PCB (138+153+180) at 3-, 6-, and 12 
months (m) with probability (p), effect size (r), and number of mothers (n) not breastfeeding, or breastfeeding, 
over or under 30 years of age. 
PCB-congeners p r n (nover 30/nunder 30) 
Not breastfeeding at the time-point    
PCB-118 3m 0.026 0.6 12 (6/6) 
PCB-138 3m 0.002 0.8 12 (6/6) 
PCB-153 3m 0.004 0.8 12 (6/6) 
PCB-180 3m 0.026 0.6 12 (6/6) 
sum PCB (138+153+180) 3m 0.004 0.8 12 (6/6) 
PCB-138 6m 0.002 0.6 25 (13/12) 
PCB-153 6m 0.011 0.5 25 (13/12) 
PCB-180 6m 0.005 0.5 25 (13/12) 
sum PCB (138+153+180) 6m 0.001 0.6 25 (13/12) 
PCB-180 12m 0.032 0.3 50 (31/19) 
    
Not breastfeeding at 6 months compared to 12 
month serum concentration 
   
PCB-118 12m 0.002 0.6 25 (13/12) 
PCB-138 12m 0.010 0.5 25 (13/12) 
PCB-153 12m 0.016 0.5 25 (13/12) 
PCB-180 12m 0.013 0.5 25 (13/12) 
sum PCB (138+153+180) 12m 0.002 0.5 25 (13/12) 
    
Breastfeeding at 3 months    
PCB-180 3m 0.008 0.3 59 (36/23) 
 
For the children, the mothers’ serum PCB-difference due to age, only had an impact on those 
that were still breastfed at 12 months. Children of mothers over 30 years of age had higher 
serum levels of PCB-153 (p=0.012, r= 0.74, n=11, nmothers-over30years=8, nmothers-under30years=3), 
PCB-138 (p=0.024, r= 0.68, n=11, nmothers-over30years=8, nmothers-under30years=3) and sum PCB 
(138+153+180) (p=0.012, r= 0.74, n=11, nmothers-over30years=8, nmothers-under30years=3), than children 
of mothers below 30 years of age at 12 months.  
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3.4.6 Parity 
The only significant difference between serum PCB-concentrations in mothers with previous 
children and mothers with no previous children, was for PCB-153 at 6 months, where there was 
a significantly higher serum level among mothers with no previous children (p= 0.03, r= -0.26, 
n= 71).  
When including breastfeeding at 6 months it was evident that this difference in PCB-153 at 6 
months was only among the breastfeeding mothers (p= 0.041, r= -0.29, nfirst-child= 24, nwith-previous-
children= 26). Mothers without previous children that breastfed daily at 12 months had also higher 
serum concentrations for both PCB-138 (p= 0.009, r= -0.55, nfirst-child= 12, nwith-previous-children= 
10) and PCB-153 (p= 0.043, r= -0.44, nfirst-child= 12, nwith-previous-children= 10), even though this did 
not show up when testing only for parity.   
There were no significant differences in the serum concentrations of PCBs among children with 
or without siblings at the different time points.  
3.4.7 Gender, Birth weight and Length 
There was little difference in the PCB-concentrations between girls and boys. The only 
difference occurred at 3 months for PCB-138 where boys had more PCB-138 than girls did 
(p=0.031, r=0.3, nboys= 27, ngirls= 19). There was also a tendency for boys to have a higher 
concentration than girls for PCB-153 at 3 months (p= 0.055, r=0.3, nboys= 27, ngirls= 19). 
A Spearman’s Rho correlation showed no significant correlations between weight at birth and 
serum PCB-levels at 28th week in gestation for the mother. There was neither any significant 
difference between children below or above 2.8 kg (15th percentile girls WHO growth for age). 
There was however, a weak trend for all the PCBs towards a higher median PCB (among 
mothers at 28th week gestation) among the children below 2.8 kg (PCB-118: p= 0.092, nover= 
37, nunder= 7, PCB-138: p= 0.120, nover= 37, nunder= 7, PCB-153: p=0.144, nover= 37, nunder= 7, 
PCB-180: p= 0.153, nover= 37, nunder= 7). 
There was no difference in serum PCB-concentrations among children over or under WHOs 
length-for-age at 0 weeks (49.1 cm) (WHO, 2014).  
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3.4.8 Breastfeeding 
Children exclusively breastfed at 3 months had significantly higher serum PCB-levels at 3 
months compared to those that had not been exclusively breastfed (Table 3.11).  
There was also a significant difference in PCB-138 for mothers at 12 months, where those that 
exclusively breastfed their child for 3 months had lower serum concentrations than those that 
had not exclusively breastfed for 3 months (p=0.045, r=-0.2, nbreastfeeding=43, nnot-breastfeeding=24). 
For PCB-118, -153, and -180 there were no significant differences among mothers after fully 
breastfeeding for 3 months.  
At 6 months there were only 7 children that had breast milk as the only nutritional source. The 
parameter “breastfeeding daily” was therefore used instead of “exclusively breastfeeding”. 
Children that were breastfed daily for 6 or 12 months had significantly higher serum PCB-
concentrations for all the PCB-congeners compared to the children that were not breastfed daily 
(Table 3.11). 
No significant differences were found between the PCB-concentrations for the mothers that 
breastfed daily for 6 or 12 months.   
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Table 3.11 Effect of breastfeeding on PCBs: Breastfeeding significance (Mann-Whitney-test) on PCB-118, -
138, -153 and -180 concentrations for 3-, 6-, and 12 months (m) with probability (p), number (n) of children (C), 
effect size (r) and median with interquartile range (IR) in ng/ml serum for breastfed and not breastfed children. 
 p r n total 
(nbreastfed/nnot 
breastfed) 
Median±IR 
(ng/ml) 
Breastfed 
Median±IR 
(ng/ml) 
Not breastfed 
3 months breastfed exclusively     
PCB-118 C3m 0.035 0.3 46 (29/17) 0.03 ± 0.02 0.02 ± 0.02 
PCB-138 C3m 0.004 0.4 46 (29/17) 0.08 ± 0.06 0.03 ± 0.08 
PCB-153 C3m 0.001 0.5 46 (29/17) 0.1 ± 0.1 0.04 ± 0.09 
PCB-180 C3m 0.001 0.5 46 (29/17) 0.09 ± 0.06 0.04 ± 0.04 
Sum PCB (138+153+180) C3m 0.001 0.5 46 (29/17) 0.3 ± 0.02 0.1 ± 0.2 
6  months breastfed      
PCB-118 C6m p<0.001 0.6 61 (42/19) 0.03 ± 0.02 0.01 ± 0.01 
PCB-138 C6m p<0.001 0.6 61 (42/19) 0.07 ± 0.06 0.02 ± 0.02 
PCB-153 C6m p<0.001 0.6 61 (42/19) 0.1 ± 0.1 0.03 ± 0.04 
PCB-180 C6m p<0.001 0.6 61 (42/19) 0.08 ± 0.07 0.02 ± 0.02 
Sum PCB (138+153+180) C6m p<0.001 0.6 61 (42/19) 0.3 ± 0.2 0.07 ± 0.08 
12 months breastfed      
PCB-118 C12m p<0.001 0.5 52 (17/35) 0.04 ± 0.02 0.02 ± 0.02 
PCB-138 C12m p<0.001 0.5 52 (17/35) 0.1 ± 0.1 0.04 ±0.06 
PCB-153 C12m 0.001 0.5 52 (17/35) 0.1 ± 0.1 0.1 ± 0.1 
PCB-180 C12m 0.003 0.4 52 (17/35) 0.11 ± 0.07 0.05 ± 0.09 
Sum PCB (138+153+180) C12m 0.001 0.5 52(17/35) 0.4 ± 0.3 0.2 ± 0.2 
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4. Discussion 
Seafood contains important nutritional components like high quality proteins, omega-3 PUFAs, 
and iodine. However, it will also contain some contaminants, which can have a potential 
negative effect on human health. The goal of this project was to evaluate the seafood intake and 
the serum levels of PCB-118, -138, -153, and -180 in mothers at 28th week in gestation and for 
mother and child at 3-, 6- and 12 months postpartum in a coastal study population.  
4.1 Participants  
The study population is very similar to the MoBa cohort in mean age (Present: 30 ± 5, MoBa: 
29.6 ±4.6) (Brantsaeter et al., 2008). This is also consistent with the average age of all 
childbirths in Norway, which was 30.4 in 2011 (SSB, 2013). BMI is also equal to the MoBa 
cohort (Present: 24 ± 4, MoBa: 24.2 ± 4.4) (Brantsaeter et al., 2008). However, the percentage 
of participants with normal weight before pregnancy was larger in this study population than 
the MoBa (Present: 59%, MoBa: 53.4%) (Brantsaeter et al., 2008). There is also a slightly 
higher degree of university/college educated women (Present: 61-71%, MoBa: 58.3%) in the 
present study population (Brantsaeter et al., 2008). This degree of higher education was 
considerably higher than the national average in 2010 (SSB: 30.6%) (SSB, 2014). There were 
also more first time mothers in this study population than in the MoBa cohort (Present: 49%, 
MoBa: 40.3%) (Brantsaeter et al., 2008). 
The children’s length and weight at birth were also very similar to what was observed for the 
children in the MoBa cohort (Brantsaeter et al., 2012). They were also inside 2 SD of the median 
length and weight for the WHO Child Growth Standards (WHO, 2014). When it comes to 
breastfeeding, 70% of the children were breastfed daily at 6 months and 33% at 12 months. 
This is 10 and 13% below the average found in the Spekost 2006-2007 study (Øverby, 2008; 
Øverby, 2009). In the MoBa cohort there was also a 10% higher degree of partially 
breastfeeding at 6 months (Haggkvist et al., 2010) Parity is one factor associated with longer 
duration of breastfeeding (Lande et al., 2003), and could explain why the women in this study 
population stopped breastfeeding earlier than other studies.  
This study population lived by the coast, and had a majority of highly educated, as well as 
pregnant/formerly pregnant women, the results from this project are therefore not necessarily 
representative for the whole Norwegian population. It has been reported that mothers with 
  Discussion 
46 
 
higher education tend to have different eating habits than those with lower education, such as a 
higher consumption of healthy food and cod liver oil (Johansson et al., 1999; Brustad et al., 
2004). The education level of the participants in this study should therefore be taken into 
consideration when interpreting the results.   
4.2 Seafood intake 
This study population consumed a smaller amount of seafood than what is recommended by 
the Norwegian Health Authorities (Nasjonalt Råd for Ernæring, 2011). Most of the women in 
this study reported eating seafood for dinner 1-2 times per week. Looking at the estimated 
summarised seafood intake per week the total was between 243 g at 28 weeks and 308 g at 12 
months. At 6- and 12 months the majority of the women ate more than 2 portions (150 g) of 
seafood, based on this estimate, which would be within the recommended quantity. At 28th 
week in gestation, and at 3 months, the estimated consumption per week was below 300 g. Thus 
the majority of the women would be below the recommendations of 2-3 portions per week at 
these time-points. On the question of total seafood for dinner the estimate was 225 g/week for 
all the time-points. Based on this the majority would be below the recommended seafood intake. 
The Norwegian Health Authorities also recommend eating about 200 g of oily fish per week 
(Nasjonalt Råd for Ernæring, 2011); whereas the estimated quantities consumed in this study 
population were between 53 and 83 g per week, which mean that most of the women were 
below the recommended intake. The low fish consumption in this study population was 
comparable to the fish intake in the MoBa study, where they consumed on average 252 g/week 
of total seafood and 84 g/week of oily fish (Brantsaeter et al., 2012). The present study was 
comparable to the Norkost 2010-2011 studies average of 308 g/week in total fish consume, but 
below the Norkost studies 154 g/week of oily fish (The Norwegian Directorate of Health, 2012). 
At the same time the Norkost study also found that only about 1/3 of the participants consumed 
the recommended amount of fish. Only 7-17% of the women in this study population reported 
eating seafood as spread 3 or more times per week, and around 70% of the women that 
consumed seafood as spread reported that they used an oily spread. These women with high 
intake of oily spread might get an additional 75g (+) of oily fish, and this can get them closer 
to the recommendations. Still, this is a very small part of the study population, and the overall 
seafood consumption is low.  
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Considering the consistent low intake of oily fish reported in the 4 questionnaires in this study 
population, it is likely that the majority of these women also had a moderate to low oily fish 
intake before pregnancy.  
Since the total seafood for dinner estimate was lower than the combined seafood categories for 
dinner estimate this might imply a possible over-reporting on the subcategories of fish 
consumed, which is a usual occurrence with an increased amount of questions (Cade et al., 
2002).  
The fact that these women do not eat the recommended amount of seafood might mean that 
they do not get enough of the nutrients from fish, like omega-3 PUFAs, vitamin D, and iodine. 
However, they might still get the amount of omega-3 PUFAs, and vitamin D, they need by 
taking supplements. At 3- and 6 months the majority of the women reported taking omega-3 
supplements more than 4 times a week, but at 12 months this intake had decreased to under 
50%. Pregnant women are recommended to take vitamin D supplements in form of cod liver 
oil during the pregnancy, which also include omega-3 PUFAs (The Norwegian Directorate of 
Health, 2009).  
Most omega-3 supplements produced in Norway have been purified to remove dioxins and dl-
PCBs (FHI, 2008). In 2010, when this study started, NIFES found no omega-3 products above 
5ng TE/kg oil, which is the upper limit for sum PCDD/F + dl-PCB in oils for human 
consumption (NIFES, 2011b). For 7 out of 17 omega-3 oils the PCB7 –concentration was above 
10 µg/kg oil, and two seal oil products above 50 µg/kg oil (NIFES, 2011b). The EU has an 
upper limit for PCB6 in oils for human consumption at 200 µg/kg oil and all the omega-3 oils 
measured by NIFES in 2010 were well below that limit (EU, 2006, 01.09.2012). The 
contribution of PCBs from omega-3 supplements are therefore worth considering, especially 
among those that consume seal oil every day. In this study there were only 3 mothers that used 
seal oil. The contribution of PCBs from seal oil was therefore negligible. Breastfeeding infants 
had a higher intake of omega-3 products than the not breastfeeding infants, the additional PCBs 
from omega-3 supplements might separate the breastfeeding infants even further from non-
breastfeeding infants in serum PCB-concentrations.  
The fact that there was a correlation between seafood for dinner and total seafood against 
reported focus on a healthy lifestyle at 28th week in gestation and at 3 months, but not later, 
might imply that mothers were more concerned about healthy nutritional intake while 
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breastfeeding. At 6- and 12 months most children had also started receiving other sources of 
nutrition than breast milk. A British study of 57 pregnant women found that they received most 
of their information about pregnancy through books and magazines (Cade et al., 2002). 
Norwegian Health Authorities have a great deal of information on healthy eating during 
pregnancy, and postnatally, available both as articles online (https://helsenorge.no/gravid), and 
as pamphlets available online and at health stations (The Norwegian Directorate of Health, 
2009; 2011). The high majority of educated women in this study also makes it more likely that 
the women would educate them self about pregnancy.  
4.3 Serum PCB-concentrations 
PCB-118, -138, - 153 and -180 were detected in mothers in the 28th pregnancy week and for 
mothers and children at 3-, 6-, and 12 months postpartum.  
4.3.1 Mothers 
The PCB-levels in the present study population were at least 6 times lower than the 95th 
percentile reference values (RV95) from the German Environmental Survey (1998) (Schulz et 
al., 2011) (Appendix 5: Table A.10). On the other hand, PCB-levels in this study, 28th week in 
gestation, were comparable to those reported in a Danish study (Morck et al., 2014). The Danish 
study reported a median serum PCB-138 level of 0.121 ng/ml (Morck et al., 2014), while in this 
project the median serum level for all the mothers were 0.07 ng/ml in the 28th gestation week. 
The PCB-153 median serum level in this project was 0.13 ng/ml, which was below the Danish 
PCB-153 serum level of 0.181 ng/ml (Morck et al., 2014). The serum level of PCB-180 was 
lower in the Danish study, with 0.024 ng/ml (Morck et al., 2014), compared to the serum median 
level measured in the present project of 0.08 ng/ml. PCB-118 was not measured in the Danish 
study, but the median serum level in the present project is below Spanish 4 year olds that had 
an average serum concentration of 0.1 ng/ml (Grimalt et al., 2010) compared to 0.03 ng/ml in 
this project. The Spanish study (Grimalt et al., 2010) also had higher serum levels for the three 
other PCBs than what was found in the present project. 
The reduction in PCB-concentrations for PCB-118, -153 and -180 between 28th week in 
pregnancy and postpartum time-points, but not between postpartum time-points, indicates that 
the majority of the PCB-transfer happened before birth. Redistribution of PCBs during 
pregnancy could be explained by the higher hormonal activity, compared to non-pregnant 
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individuals, as well as an increase in blood volume by 40-50% (Lockitch, 1997; Costantine, 
2014). The metabolic systems are also affected, and there might be more cholesterol and other 
fatty lipids in the blood than normal (Costantine, 2014). The changes in serum-PCB from 
pregnancy to postpartum may come out differently if compared to pre-pregnancy serum 
samples. After birth the blood values can also be influenced by weight loss and breastfeeding. 
The total impacts from these, as well as exogenous PCB-intake from seafood, were therefore 
what was measured in serum after birth. 
PCB-concentrations can be influenced by confounding factors like BMI, age, living area 
(urban/not urban), previous children, high alcohol consumption, high fish consumption and 
consumption of seagull eggs and roe liver pate (Rogan et al., 1986; Schade et al., 1998; 
Caspersen et al., 2013; Morck et al., 2014). In the current project possible factors to consider 
were BMI, age, previous children, fish consumption, roe liver pate consumption, and fish liver 
consumption.  
BMI had no impact on the concentrations of PCBs when the population was divided into above 
and below a BMI of 25 (normal weight or overweight). Overweight women will have more 
adipose tissue to distribute the PCBs over, thereby diluting the concentration of PCBs. Women 
with a high BMI have been found to have lower concentrations of PCBs in breast milk, and it 
is reasonable to expect this also in serum (Schade et al., 1998). The previous observations were 
not found in the present study, probably due to the low number of obese in the studied 
population.  
Age had a significant impact on the serum PCB-concentrations. Among breastfeeding mothers 
a difference in PCB-concentrations between those over and under 30 years of age was detected 
only before birth. Mothers that did not breastfeed had a significant difference in concentrations 
throughout the first year after birth. Other studies have also found that PCB-concentrations are 
age dependent (Schade et al., 1998; Glynn et al., 2007; Schulz et al., 2011). The higher levels 
of PCBs in mothers over 30 years of age are probably due to a longer lifetime of 
bioaccumulation, and also from declining PCB-concentrations in nature and food during the 
last decades (Glynn et al., 2007; Axmon et al., 2008; EFSA, 2012b). This decline means that 
the eldest mothers have been exposed to higher concentrations of PCBs early in life than 
younger mothers. This higher PCB-concentration, among those over 30 years of age, might 
therefore be more of a birth cohort effect than an effect of aging (bioaccumulation and slower 
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metabolism) (Quinn et al., 2012). After birth the PCB-difference between mothers over and 
under 30 years of age disappeared in breastfeeding mothers. This is concurrent with other 
studies that states that previously breastfeeding women show lower levels of PCBs than women 
that have not breastfed (Wittsiepe et al., 2007; Bjermo et al., 2013).     
There was also a difference in the PCB-distribution between those that had previous children 
and those that did not. This was only evident among those who breastfed their child. 
Breastfeeding mothers without previous children had a higher level of PCB-153 at 6 months 
than breastfeeding mothers with previous children. At 12 months the mothers without previous 
children, that still breastfed, had higher levels of both PCB-138 and -153 compared to 
breastfeeding mother with previous children. These are among the most abundant PCBs, and 
that might be the reason why only these PCBs show a difference. It has been established that 
women with previous children have lower PCB-concentrations, many new studies on PCBs 
therefore only use primiparous women (Schade et al., 1998; Glynn et al., 2007; WHO, 2007). 
There was no question in the seafood-FFQ about breastfeeding previous children. This may 
have masked a difference that might have occurred by looking at mothers that had previously 
breastfed against mothers that used formula. 
4.3.2 Children 
The majority of the studies in Table A.10 (Appendix 5) are on children of school age, as there 
are few studies that assess PCB-concentrations in serum for infants. These serum PCB-levels 
are therefore more of a reference to the concentrations for the infants in this study. The median 
for all the infants are used here, since the other studies do no separate between breastfed and 
not breastfed children.  
It is apparent that the German whole blood and cord blood PCB-levels, as well as the Spanish 
serum PCB-levels (Table A.10 (Appendix 5)) are far higher than the median serum PCB-levels 
for the children in the present study (Lackmann, 2002; Grimalt et al., 2010; Schulz et al., 2011). 
The 6 to 11 year old children in the Danish study (Morck et al., 2014) are more comparable in 
median PCB-levels to the Norwegian infants studied in this project. In the Danish study the 
serum median level of PCB-138 was 0.086 ng/ml (Morck et al., 2014), while it in this project 
was 0.06 ng/ml 3 months after birth. Serum median level of PCB-153 was 0.118 ng/ml (Morck 
et al., 2014) in the Danish study and 0.1 ng/ml in the present project. For PCB-180 the serum 
median level was 0.072 ng/ml (Morck et al., 2014) in the Danish study and 0.06 ng/ml in the 
  Discussion 
51 
 
present project 3 months after birth. As previously mentioned PCB-118 was not measured in 
the Danish study, but Spanish 4 year old children had an average serum concentration of 0.10 
ng/ml (Grimalt et al., 2010), which was 3 times higher than the median serum level of 0.03 
ng/ml measured in this project at 3 months after birth. There was only one child, in the present 
project, above the reference values for PCB-138 and PCB-180 suggested by Lackmann (2002) 
for serum concentrations in neonates. The child had been breastfed for more than 6 months, and 
a concentration over the neonate reference value is therefore not so unlikely (Verner et al., 
2013). Based on current knowledge this is unlikely to cause an increased health risk since the 
PCB-levels of breastfed children tend to decrease as they grow and put on more fat (Verner et 
al., 2013). That both this and the Danish study population have lower serum PCB-levels than 
the German and Spanish concentrations, indicates geographical differences in PCB-levels, 
which are lower in Norway and Denmark than in other European countries. Both Grimalt et al. 
(2010) and Lackmann (2002) have values from children born in 1997-1998. These are born 
more than 10 years before the children in this project. This might contribute to a birth cohort 
effect, and might account for some of the difference between these values.  
There was little difference in the median serum PCB-levels among the infants as they got older. 
This was also seen when the children were divided into breastfeeding and not breastfeeding. 
Other studies have not found the same results. In a toxicokinetic model by Verner et al. it was 
found that the child’s PCB-concentrations would increase as long as the child was breastfed 
(Verner et al., 2009; Verner et al., 2013). In the Inuit Cohort Study children breastfed for more 
than 3 months had four times higher PCB-153 concentration at 6 months than those that were 
breastfed for less than 3 months (Ayotte et al., 2003). The difference between this cohort and 
the Inuit cohort is that 55% of the children continued with exclusive breastfeeding after 3 
months in the Inuit cohort. Whereas, in this project only 7% of the children were exclusively 
breastfed at 6 months. The children in the Inuit cohort therefore probably received more breast 
milk than most of the children in this study, and consequently had a higher PCB-concentration. 
Earlier studies have linked a high PCB-transfer to the infant during pregnancy to lower birth 
weight (Govarts et al., 2012; Papadopoulou et al., 2013). This was not found in this project. 
However, there was a tendency towards higher PCB-concentrations in mothers (28th week in 
gestation) that had children below 2.8 kg at birth. There were only 7 children below 2.8 kg and 
37 above 2.8 kg. Although the number of participants in this project was limited it is tempting 
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to suggest that high PCB-levels in mother leads to a reduction in birth weight as observed 
previously for PCB-153 (Govarts et al., 2012).   
Breastfeeding children of mothers over 30 years of age had elevated levels of PCB-138, and -
153 at 12 months. Older mothers often breastfeed longer than younger mothers (Lande et al., 
2003; Betoko et al., 2013), which was also apparent in this study population. In this test 8 of 
the 11 children, that were still breastfeeding at 12 months, had mothers over 30 years of age. 
Longer duration of breastfeeding can lead to increased concentrations of PCBs in serum 
compared to children not breastfed for so long. This might be the reason why mothers over 30 
years of age had children with higher serum levels for some PCBs at 12 months.   
Although Quinn et al. (2012) found that the first-born child would have a higher prenatal PCB-
transference than the second- to fifth-born child, parity had no impact on serum PCB-levels in 
the children in this project.  
There was a significant difference in the median between breastfed and formula fed children, 
with higher serum PCB-concentrations among the breastfed infants. This is consistent with 
previous studies, where the increased PCB-concentrations in breastfed children could still be 
detected several years after the nursing period (Lanting et al., 1998a; Walkowiak et al., 2001; 
Ayotte et al., 2003; Carrizo et al., 2006).  Breast milk is known to contain PCBs from the 
mother, and these will be transferred to the child (VKM, 2013). At the same time more children 
received omega-3 supplements in the breastfeeding group compared to the formula fed group. 
Ordinary Möllers tran, one of the most common cod liver oils in Norway, had 22 µg PCB7/kg 
oil in 2010 (NIFES, 2011b). This supplement intake can possibly contribute to a higher PCB-
intake among the breastfed children, but this is unlikely due to the small servings given to 
children. Some studies show a slight decline in PCB-concentrations in breast milk during the 
nursing period with about 1-3% per month, after a year the reduction can be up to 15 to 28% 
(Hooper et al., 2007; Thomsen et al., 2010). This can explain why the children levelled out in 
PCB-concentration; they are growing and accumulating more fat to store the PCBs in and at the 
same time their mothers are giving out declining amounts of PCBs through their milk. The 
breastfed children were still below other European countries in concentration. In addition the 
benefits from breastfeeding would likely outweigh any possible negative effect from this PCB-
consumption, as was the conclusion of the Norwegian Scientific Committee for Food Safety in 
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2013 (VKM, 2013). This suggests that there is little reason for Norwegian mothers to not 
breastfeed to avoid PCB-transference from mother to child.  
4.3.3 Comparison of PCB-concentration in mother and child 
There were 20 children and 27 mothers that had longitudinal PCB-data from all the time-points. 
Since there was no difference in PCB-concentrations between these and the other participants 
these account for a representative selection of the study population and are therefore used to 
look at the difference in PCBs over the time-points.  
In this study the not breastfed infants had lower serum PCB-concentrations at 3 months than 
mothers’ serum PCB-concentrations at 28th week in pregnancy. The breastfed infants had 
concentrations equal to or higher than the mothers’ serum PCB-concentrations at 28th week in 
pregnancy. This was also evident in the correlation between mother and child at 3 months where 
all the PCB-congeners showed a significant correlation with higher levels among most of the 
children. That the mothers have reduced some of their serum PCB-concentrations from 28th 
week in pregnancy to postpartum, might indicate a transfer of the PCBs from mother to child. 
It is normal that children have PCB-levels similar to the mothers at birth, and for the PCB-levels 
of breastfeeding infants to increase to above mothers’ concentration during the breastfeeding 
period (Grandjean, 2003; Verner et al., 2013; VKM, 2013). The increase found in the breastfed 
children, but not in the formula fed, is consistent with what other studies have found (Ayotte et 
al., 2003; Lackmann et al., 2005). 
At birth this PCB-concentration would be what was transferred over the placenta during the 
pregnancy. At 3 months after birth the amount of PCBs in the infants serum is both from transfer 
over the placenta and through breast milk.  
The only significant correlation between mother and child at 6 months was for PCB-180, which 
also had the strongest correlation at 3 months. The median is still lower for PCB-118, - 138 and 
-153 for the mothers compared to the children at 6 months. This difference disappears before 
12 months. At 12 months there were no longer any exclusively breastfed children, and close to 
70% of the children were not breastfed at all. For those that stopped breastfeeding before, or 
right after 6 months, the growth of the child from this period to 12 months likely lead to a 
diluted body burden of PCBs (Verner et al., 2013). This dilution may cause the lack of 
difference between mother and child at this stage.  
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 4.4 Seafood consumptions impact on serum PCB-concentrations 
Mothers that consumed fish liver had increased PCB-concentrations compared to those that did 
not consume fish liver. Children of mothers that consumed fish liver only had an increase in 
serum PCB-138 concentration at 3 months. Fish liver has been found to have a high PCB-
concentration, as is also documented in Table 1.1 in part 1.3 in the Introduction. Fish liver and 
seagull eggs are especially high in PCBs, and MoBa found that pregnant women that consumed 
sea gull eggs and roe liver pate, containing fish liver, had higher serum level of PCB-153 
compared to the rest of the study population (Caspersen et al., 2013). Fish liver is traditionally 
consumed in many coastal communities, and the study population here do live by the coast. 
Both MoBa and the Norwegian Fish and Game Study considered fish liver in their intake, but 
found that it had little impact on overall median and total intake (Kvalem et al., 2009; Caspersen 
et al., 2013). 
The only correlation that appeared between seafood and PCB-concentration in serum at 28th 
week of pregnancy was for shellfish (PCB-153, and -180) and this was an effect of medium 
size. Shellfish is normally low in PCBs (Fernandes et al., 2009; Gueguen et al., 2011), the 
correlation here is therefore difficult to explain. One possible explanation is the consumption 
of older shells, crabs and lobsters, which can have bioaccumulated more PCBs over time, as 
observed for shells where PCB-concentration increased with age (Grilo et al., 2013). However, 
the concentration of PCB7 in Norwegian blue mussels, scallops and oysters were in 2010 found 
to be generally low, and comparable to that of lean fish (NIFES, 2011a). Shellfish consumers 
might have a more including eating pattern, with an increased consumption of different sorts of 
seafood. When removing the fish liver consumers from the data set the shellfish correlation 
disappeared. This might implicate fish liver consumption as the reason behind the shellfish 
correlation 
Seafood intake, both total dinner intake and oily fish consumption, had little impact on serum 
PCB-concentrations in the mothers. The only influence from oily fish, found in this study, was 
for mothers that consumed more than 300 g per week at 6 months. This was only evident for 
PCB-180 and only among those that did not breastfeed. There were only three mothers that did 
not breastfeed and at the same time consumed more than 300 g of oily fish at this stage, the 
statistics here are therefore less reliable. Semi-oily and oily fish were found to be the largest 
contributor to PCB-intake, among those that did not consume seagull eggs and roe liver pate, 
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in the MoBa cohort (Caspersen et al., 2013). The majority of the women in this study population 
were breastfeeding, and the exogenous exposure from oily fish might be masked by this. This 
is concurrent with the observation that only non-breastfeeding mothers had a higher PCB-180 
at 6 months due to oily fish consumption. At the same time, the consumption of oily fish was 
low in this study population, which might be why no relationship appears. When removing the 
2 fish liver consumers that had an oily fish intake above 300 g at 6 months, the PCB-180 
difference in serum concentration disappeared. Fish liver consumption is therefore also likely 
the cause of the higher PCB-180 serum concentration at 6 months for those that consumed over 
300 g of oily fish per week. 
4.5 Methodological considerations and potential improvements 
4.5.1 Seafood-FFQ 
This study is undertaken in pregnancy and nursing period, and during this time pregnancy 
complications may arise. This might be nausea, vomiting or bed rest. These are conditions that 
also affect the diet, but can be difficult to capture in an FFQ (Meltzer et al., 2008). In this study 
the seafood-FFQ only asked for habitual seafood intake for the last 3 months. Eventual 
pregnancy complications were therefore also reflected in these questions, perhaps better than 
in an FFQ considering the last 12 months. Still it would be useful with a question about 
particular food items, especially seafood, that the participant were not able to consume during 
the pregnancy, or in the months after, because of pregnancy nausea or the state of the pregnancy. 
This would make it possible to see if the women ate less fish during that period than they would 
normally. 
The question on daily exercise (12D) in the seafood-FFQ should be changed from 20 minutes 
to 30 minutes per day. This is the recommended amount of moderate to high exercise needed 
per day. This is also applicable for pregnant women, but there only for 5 days a week (The 
Norwegian Directorate of Health, 2014). There should also be other options, like hard 
exercising for 60 minutes. Since some PCB-congeners are found in sweat, increased 
perspiration might lead to a higher elimination of these PCBs (Genuis et al., 2013). Very active 
women might therefore have lower PCB-levels than not so active women.  
The Norwegian Health Authorities recommend eating fish for dinner 2-3 times per week 
(Nasjonalt Råd for Ernæring, 2011). In the seafood-FFQ the frequency is either 1-2 times per 
  Discussion 
56 
 
week or 3 or more per week it is not possible to say if these women eat the recommended 
amount, or just 1 portion. This question should be changed according to the Norwegian 
recommendations.  
4.5.2 Blood samples 
Blood samples were in this study taken in a nonfasting state, which have been found to be as 
much as 29% higher in PCBs than fasting samples (Phillips et al., 1989). This difference evens 
out when the samples are corrected for total lipid concentration. Since PCBs are in a dynamic 
equilibrium among all tissues in the body, an alteration of lipid content in one of these tissues 
would change this equilibrium (Matthews et al., 1980). More serum lipids in the blood after a 
meal can thereby possibly extract some PCBs from the muscle and liver. Muscle and liver have 
a high perfusion rate and some affinity for PCBs but bind it weaker than lipoproteins in the 
blood (Matthews et al., 1980). The serum PCB-concentrations in this project were not adjusted 
for lipid concentration. There have been found good correlations between nonfasting PCB-
concentrations in serum samples and their corresponding lipid adjusted values (Rylander et al., 
2012). Good correlations have also been found between adipose tissue and serum (Stellman et 
al., 1998). The concentrations found in this project are therefore viable to be used as biomarkers 
of total body burden of PCBs. 
 Neither of the articles in Table A.10 (Appendix 5) state if the blood sampling were done from 
fasting or non-fasting subjects. In this project blood was drawn in a nonfasting state. It is normal 
to collect blood samples in a fasting state, especially when studying lipoprotein and metabolic 
processes, since this is thought to give a more defined baseline and be more reproducible (Cohn 
et al., 1988).  
Blood from children are rarely collected in a fasting state. This should therefore not affect the 
measured PCB-concentrations. Considerably fewer serum samples were analysed for the 
children than the mothers. Drawing blood from infants is more challenging than from adults. 
Therefore there are some children that have not had their blood taken at some of the time-points. 
The serum samples have also been used previously for other studies. Some vials were therefore 
empty when they were to be analysed and had to be excluded. 
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4.5.3 PCB-analysis 
The analytical method used for analysing the four PCBs has not been fully validated or 
accredited. Hence, its associated uncertainty has not yet been established. To assure that the 
analytical quality of the method was sound some parameters needed to ensure reliable results 
were implemented, as explained in Materials and Method section 2.7. Two samples of Certified 
Reference Material (CRM) were run almost every day. Not all of them came out inside the 
desired concentrations. The majority of times this happened for only one of the two CRMs, or 
the CRM was incorrect for only one analyte. The decision was therefore made that it would not 
be correct to disregard the samples made that day. In future analysis with this method more 
CRM-samples (3+) should be analysed together with the samples. CRM and BL-values are 
illustrated with bar graphs (Figure A.4 to A.11) in Appendix 4. A t-test was also completed on 
the recovered values of the CRM. Samples below 30% and above 130% recovery were removed 
from the dataset. Inside this range previous results from HRGC-HRMS analysis have been 
relatively robust. Some parallel samples showed too high variation. New samples were prepared 
for these and other samples that were excluded due to abnormal elution of compounds of 
interest in the chromatogram. The HRGC-HRMS developed a malfunction before these could 
be run and could not be fixed in time to get the results into this project. Mean values for the 
parallels were therefore used in this project. The amount of congeners found, with PCB-153 
being the largest concentration, and PCB-118 being the smallest, are coherent with what other 
studies have reported. The PCB-concentrations were also different between older and younger 
mothers, as well as increasing with breastfeeding length for the children. This is also in 
agreement with other studies (EFSA, 2005; VKM, 2013). These observations strengthens the 
validity of the method.  
The statistics used in this project does not fully account for possible confounding factors (BMI, 
parity, smoking, alcohol consumption, seafood intake) that can influence the PCB-levels 
studied in these mothers and children. In the future, a multilevel linear model should be used to 
get a complete view of the impact from these factors. Unfortunately, constructing a multilevel 
linear model is a time consuming task that could not be considered in the present master project. 
A recoding with the established and missing values were performed so that it was possible to 
observe the differences between those in the study population that had a complete sample set, 
and those that had not. 
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5. Summary and conclusion 
Maternal fish consumption was lower than the recommendations given by the Norwegian 
Health Authority for both total fish and oily fish. 
The newly established method for measuring PCBs in small serum volumes appears reliable for 
detection of PCB-118, -138, -153 and -180. 
The current serum levels of PCB-118, -138, -153 and -180 in Norwegian mothers and children 
were low compared to other European countries.  
There was a correlation between serum levels of PCB-118, -138, -153 and -180 in mother and 
child 3 months after birth. The only other serum PCB correlation between mother and child was 
for PCB-180 at 6 months after birth. 
Whereas breastfeeding in itself had little impact on maternal PCB-concentrations in serum, 
breastfed children had an increase in serum PCB-levels compared to not breastfed children. 
The serum PCB-levels increased with age and decreased with parity in not-breastfeeding and 
breastfeeding mothers respectively.  
Fish liver consumers were found to have higher serum PCB-levels than the rest of the study 
population. Children of fish liver consumers only differed in serum concentration of PCB-138 
at 3 months. 
To achieve the overall beneficial health effects from seafood, young and pregnant women 
should increase their seafood consumption, but avoid fish liver products. This demonstrates the 
importance of specific dietary advice for young and pregnant women concerning fish liver 
products. 
When fish liver consumers were excluded, there were no relation between maternal fish intake 
and serum levels of PCB-118, -138, -153 and -180 in mother or child.  
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Appendix 
Appendix 1: 6 month FFQ and Seafood-FFQ  
Children: 6 month short FFQ: 
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Sjømatinntak 
Her vil vi gjerne få informasjon om sjømatinntaket ditt. Ha de 3 siste månedene i bakhodet når du fyller ut 
skjemaet. Med sjømat mener vi fisk, fiskeprodukter og andre sjømatprodukter som for eksempel skjell og 
skalldyr. Vi er klar over at kostholdet varierer fra dag til dag. Prøv likevel så godt du kan å gi et 
”gjennomsnitt” av ditt sjømatinntak spist til middag, som pålegg, i salat og eller spist som mellommåltid. Du 
skal bare sette ETT kryss på hvert spørsmål med mindre noe annet er spesifisert, og krysset skal være inne i 
en boks, ikke mellom boksene. 
1. Hvor ofte bruker du fisk, fiskeprodukter eller annen sjømat som middagsmat? 
Mer enn 5 
ganger / uke 
3 ganger eller 
mer/ uke 
1-2 ganger/uke 1-3 ganger/ 
måned 
Sjeldnere enn 1 
gang/måned 
Aldri 
□ □ □ □ □ □ 
2. Hvis du spiser fisk, fiskeprodukter eller annen sjømat til middag, hvor mye spiser du 
vanligvis?  
(1 porsjon = 150 gram, tilsvarer for eksempel 1 laksekotelett eller 3 fiskekaker eller 2 dl reker u/skall) 
1/2  porsjon eller 
mindre 
1 porsjon 1 ½  porsjon 2 porsjoner  3 porsjoner 
□ □ □ □ □ 
3. Hvor ofte bruker du sjømat som pålegg, i salat, mellommåltid, snacks eller lignende? 
Mer enn 5 
ganger / uke 
3-5 ganger / uke  1-2 ganger / uke  1-3 ganger/ 
måned 
Sjelden Aldri 
□ □ □ □ □ □ 
4. Hvis du bruker sjømat som pålegg, i salat, mellommåltid, snacks eller lignende, 
beskriv hvor mye du vanligvis spiser? 
(for eksempel boks makrell i tomat, antall fiskekaker, dl reker til antall brødskiver/knekkebrød) 
________________________________________________________________________________________
________________________________________________________________________________________
_______________________________________________________________________________________ 
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5. Hvor ofte spiser du vanligvis følgende sjømat som middag? 
 3 ganger eller mer/uke 1-2 ganger/uke 1-3 ganger /mnd Sjeldnere enn 1 gang/mnd Aldri 
Laks, ørret □ □ □ □ □ 
Makrell □ □ □ □ □ 
Sild □ □ □ □ □ 
Kveite □ □ □ □ □ 
Uer □ □ □ □ □ 
Steinbit □ □ □ □ □ 
Flyndre, rødspette □ □ □ □ □ 
Torsk □ □ □ □ □ 
Sei □ □ □ □ □ 
Hyse □ □ □ □ □ 
Abbor, gjedde (ferskvann) □ □ □ □ □ 
Røye, sik (ferskvann) □ □ □ □ □ 
Reker □ □ □ □ □ 
Krabbe □ □ □ □ □ 
Hummer □ □ □ □ □ 
Blåskjell □ □ □ □ □ 
Kamskjell □ □ □ □ □ 
Fiskekaker □ □ □ □ □ 
Fiskeboller □ □ □ □ □ 
Fiskepudding □ □ □ □ □ 
Fiskegrateng □ □ □ □ □ 
Fiskepinner □ □ □ □ □ 
Fiskesuppe □ □ □ □ □ 
Klippfisk □ □ □ □ □ 
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6. Hvor ofte spiser du vanligvis følgende sjømat som pålegg? 
 3 ganger eller 
mer/uke 
1-2 
ganger/uke 
1-3 ganger 
/mnd 
Sjeldnere enn 1 
gang/mnd 
Aldri 
Makrell i tomat □ □ □ □ □ 
Sardin på boks □ □ □ □ □ 
Brisling □ □ □ □ □ 
Ansjos □ □ □ □ □ 
Røkt laks, ørret □ □ □ □ □ 
Gravet laks, ørret □ □ □ □ □ 
Tunfisk på boks □ □ □ □ □ 
Sild (sursild, rømmesild, 
kryddersild el.lign.) □ □ □ □ □ 
Kaviar □ □ □ □ □ 
Crabsticks □ □ □ □ □ 
Svolværpostei □ □ □ □ □ 
Lofotpostei □ □ □ □ □ 
Annet sjømat (spesifiser): □ □ □ □ □ 
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________ 
 
7. Spiser du innmat av fisk? 
□ Ja  □ Nei 
Dersom ja, hvor mange ganger per år spiser du fiskeinnmat? 
 1-3 ganger/år 4-6 ganger/år 7-9 ganger/år ≥ 10 ganger/år 
Rogn □ □ □ □ 
Fiskelever □ □ □ □ 
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8. Andre generelle spørsmål om kostholdet ditt 
A. Hvor ofte spiser du frukt og grønnsaker? 
 Flere ganger/dag Hver dag 4-6 ganger/uke 1-3 ganger/uke Sjelden Aldri 
Frukt □ □ □ □ □ □ 
Grønnsaker □ □ □ □ □ □ 
B. Spiser du meieriprodukter (melk, yoghurt, ost) daglig?  
□ Ja   □ Nei (gå til spørsmål C) 
Dersom ja, hvor mange ganger per dag spiser du meieriprodukter (en gang er for eksempel ett glass melk eller 
en yoghurt eller ost til en skive brød)? 
 
1-3 ganger/dag 4-6 ganger/dag 7-9 ganger/dag ≥ 10 ganger/dag 
□ □ □ □ 
Dersom ja: Når det finnes vitamin D berikete varianter av de ulike melkeproduktene, hvor ofte velger du da 
disse? 
Alltid Som oftest Noen ganger Sjelden Aldri  Vet ikke 
□ □ □ □ □ □ 
C. Bruker du smør eller margarin? 
□ Ja   □ Nei (gå til spørsmål D) 
 
Fyll inn til hvor mange brødskiver/knekkebrød/rundstykker du vanligvis bruker smør/margarin per uke 
____ Margarin ____ Lettmargarin ____ Smør 
 
Hvor mye smører du pr. brødskive/knekkebrød/rundstykke? 
En porsjonspakning på 10-12 g rekker til antall skiver/knekkebrød/rundstykke: 
□ 1  □ 2  □ 3  □ 4  □ 5 
 
Når det finnes vitamin D berikete varianter av smør eller margarin, hvor ofte velger du da disse? 
Alltid Som oftest Noen ganger Sjelden Aldri Vet ikke 
□ □ □ □ □ □ 
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D. Angi hvilken type fett du vanligvis bruker til matlaging? 
 Daglig Ukentlig Månedlig Sjelden Aldri 
Margarin □ □ □ □ □ 
Lettmargarin □ □ □ □ □ 
Smør □ □ □ □ □ 
Oljer □ □ □ □ □ 
 
Hvis du bruker oljer, hvilken type olje bruker du vanligvis? 
□ Olivenolje  □ Soyaolje  □ Rapsolje  □ Solsikkeolje 
□ Maisolje  □ Annen olje (spesifiser): ______________ 
 
Når det finnes vitamin D berikete varianter av oljer, hvor ofte velger du da disse? 
 
Alltid Som oftest Noen ganger Sjelden Aldri Vet ikke 
□ □ □ □ □ □ 
 
9. Kosttilskudd 
A. Bruker du tran, fiskeolje- eller omega-3 tilskudd (flytende eller som kapsler)? 
 
Ja, hele året 
 
Ja, men bare om vinteren 
 
Nei  
Flytende □ □ □ 
Kapsler □ □ □ 
 
Dersom du tar flytende tilskudd: Hvor mye tran, fiskeolje eller omega-3 tar du per gang? 
1 teskje (3 ml) □ 
1 barneskje (6 ml) □ 
1 spiseskje (11 ml) □ 
 
Dersom du tar kapsler: Hvor mye tran, fiskeolje eller omega-3 tar du per gang? 
1-2 kapsler □ 
3-4 kapsler □ 
5 eller flere kapsler □ 
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Hvilken type tran- eller fiskeolje/omega-3 tilskudd pleier du å bruke og hvor ofte tar du tilskuddet? 
 
 
Daglig 
HYPPIGHET 
 
4-6 ganger/uke 1-3 ganger/uke 1-3 ganger/måned Sjelden/aldri 
 
Møllers tran  □ □ □ □ □  
Møllers dobbel  □ □ □ □ □  
Triomar  □ □ □ □ □  
Eskimo omega-3  □ □ □ □ □  
Selolje  □ □ □ □ □  
Triomega  □ □ □ □ □  
Vitomega  □ □ □ □ □  
Sunkost omega3  □ □ □ □ □  
Eldorado  □ □ □ □ □  
Pikasol  □ □ □ □ □  
Friflyt  □ □ □ □ □  
Annen (spesifiser)  □ □ □ □ □  
 
Spesifiser annet omega-3 supplement:………………………………………………… 
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B. Bruker du annet kosttilskudd (vitaminer og mineraler)? 
□ Ja  □ Nei (Gå til spm 10) 
Hvis ja, hvilke type kosttilskudd bruker du og hvor ofte?  
 Daglig 
HYPPIGHET 
 
4-6 ganger/uke 
1-3 
ganger/uke 
1-3 
ganger/måned   
  
Multivitamin 
og mineral □ □ □ □     
 
Jern □ □ □ □     
 
B-vitaminer □ □ □ □     
 
Kalsium og 
vitamin D 
□ □ □ □     
 
Annet □ □ □ □     
   
Dersom du tar kosttilskudd spesifiser hvilket og hvor mye du tar hver gang: 
________________________________________________________________________________________
______________________________________________________________ 
___________________________________________________________________________ 
 
10. Bosted og etnisitet 
A. Bor du mesteparten av året i Norge?     
 □ Ja, Sør-Norge       □ Ja, Midt-Norge      □ Ja, Nord-Norge  □ Nei, bor i annet land, 
spesifiser………… 
 
B. Er du av kaukasisk avstamning (har hvit hudfarge)?     
□ Ja  □ Nei  □ Vet ikke 
 
C. Hvilket språk snakket dere i ditt barndomshjem? 
□ Norsk  □ Annet, spesifiser……………………. 
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11. Solvaner 
A. Hvor ofte bruker du solarium?  
□ 1-2 ganger i uken   □ 2-3 ganger i mnd   □ 1 gang i mnd     □ Sjeldnere enn 1gang i mnd     □ Aldri 
 
B. Hvor mange uker de tre siste månedene har du vært på badeferie (Norge eller Syden)? 
□ 7 uker eller mer      □ 4-6 uker       □ 2-3 uker   □1 uke    □ Har ikke vært på badeferie 
 
C. Hvor mange uker de tre siste månedene har du vært på fjellet i snø? 
□ 4 uker eller mer   □ 2-3 uker   □7-13 dager  □1-6 dager  □ Har ikke vært på fjellet i snø 
 
D. Hvor mye utendørsaktivitet har du om sommeren (turer, hagearbeid, jobb)? 
□ Ute nesten hele tiden         □ Ganske mye         □ Middels       □ Lite 
 
 
12. Andre spørsmål  
 
A. Alder _______år Høyde ________cm  Vekt_______ kg    
 
B. Spørsmål kun til mor (Spørsmålene under 12B gjelder bare for dem som svarer på dette skjemaet for 
første gang): 
 
Hvor mye veide du før du ble gravid (dette svangerskapet)? _______ kg 
Har du vært gravid tidligere     □ Ja  □ Nei (Gå til spørsmål C) 
Antall svangerskap: _______ svangerskap  Antall levendefødte barn:________barn 
Fødselsdato for barnet/barna:______________________________________ 
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 C. Røyker du?                     □ Ja  □ Nei 
Hvis ja, hvor mange sigaretter/piper røyker du pr. dag? _______ 
 
Bruker du snus?         □ Ja   □ Nei 
Hvis ja, hvor mange ganger pr. dag?  _______ 
 
D. Hvor ofte mosjonerer du i minst 20 minutter (går, jogger, sykler, svømmer, fotball, aerobic, 
styrketrening eller lignende)? 
Hver dag 4-6 ganger/uke 2-3 ganger/uke 1 gang/uke 
Sjeldnere enn 1 
gang /uke Aldri 
□ □ □ □ □ □ 
 
E. Hvor stor vekt legger du på å ha et sunt kosthold? 
Svært stor Stor Middels Liten Svært liten 
□ □ □ □ □ 
 
F. Er ditt kosthold representativt for resten av familien?  
□  Ja  □  Nei 
 
 
     G. Spiser du vanligvis ett eller flere måltider om dagen sammen med resten av familien? 
□  Ja  □  Nei 
 
H. Hva er din høyeste fullførte utdanning? 
9-årig grunnskole Videregående  
Høyskole/ 
universitet inntil 4 
år (bachelor, lærer, 
ingeniør, sykepl.) 
Høyskole/ 
Universitet mer enn 
4 år (master, 
embetseksamen) 
□ □ □ □ 
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Kryss av for feltene under som ev. gjelder for deg 
□ Er vegetarianer 
□ Har diabetes (sukkersyke) 
□ Har matvareallergi/intoleranse  
□ Spiser ikke melprodukter 
□ Spiser ikke melkeprodukter 
□ Spiser ikke kjøttprodukter 
□ Spiser ikke grønnsaker 
□ Bruker medisiner Spesifiser gjerne produktnavn: 
___________________________________________________________________________ 
___________________________________________________________________________ 
 
 
TAKK FOR INNSATSEN! 
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Appendix 2: Chemicals and solution-preparations 
Table A.1 Chemicals and preparation of internal standard and recovery standard 
13C12 intern 
standard 
Art.nr Content    ng/ml 
 CLM-
1627 
13C12 pp-DDE 
 
Deluted 
with  
isopropanol 
to 
 
50 
 EC-1435 13C12 PCB-118 20 
 EC-1436 13C12 PCB-138 20 
 EC-1406 13C12 PCB-153 20 
 EC-1407 13C12 PCB-180 20 
 EO-4982 13C12 PBDE-47 25 
       
 Art.nr Content    ng/ml 
Recovery standard EC-1415 13C12 PCB-111 
Rec 
 Deluted with nonane to 40 
 
All standards are bought from Cambrigde Isotope Laboratories via LGC Sweden 
Table A.2 Chemicals used in the sample preparation for PCB-analysis  
Name Supplier 
Formic acid (HCOOH)  Merck Index-No: 607-001-000 
Acetone (C3H6O)  Sigma-Aldrich Lot # SZBD119AV 
Dichloromethane (CH2Cl2) Merck Index-No:602-004-00-3 
Isohexane (C6H14)  Merck Index-No: 401-007-00-7 
Sulphuric acid (H2SO4)  Sigma-Aldrich Lot # SZBD3190V 
Nonane (C9H2O)  Sigma-Aldrich Lot # STBC5938V 
Table A.3 Chemicals and preparation of HRGS-HRMS standard solutions 
 Standard 5 Standard 4 Standard 3 Standard 2 Standard 1 
Native stock B mix ng/ml ng/ml ng/ml ng/ml ng/ml 
p.p’-DDE 80 40 20 8 1.6 
PCB-118 40 20 10 4 0.8 
PCB-138 40 20 10 4 0.8 
PCB-153 40 20 10 4 0.8 
PCB-180 40 20 10 4 0.8 
13C12 stock B mix      
p.p’-DDE 100 100 100 100 100 
PCB-118 40 40 40 40 40 
PCB-138 40 40 40 40 40 
PCB-153 40 40 40 40 40 
PCB-180 40 40 40 40 40 
All standards are bought from Cambrigde Isotope Laboratories via LGC Sweden 
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Appendix 3: Results 
Table A.4 Healthy diet and seafood intake:  Spearman's correlation on Focus on a Healthy Diet (Healthy) against 
different categories of seafood from the S-FFQ at 28th week (w) in pregnancy and 3-, 6- and 12 months (m) 
postpartum 
  Sea-
food 
dinner  
Sea-
food 
spread  
Supple
-ment  
Total 
sea-
foodb  
Salmon  
/Trout  
Cod  Oily 
fish  
Lean 
fish  
Shell-
fish  
Proc
esse
d 
seafo
od  
Health
y 28w -    
S-FFQ 
28w 
ρ 0.303* 0.197 0.222 0.427** 0.286* 0.182 0.168 0.235 0.111 0.265 
p 0.025 0.158 0.103 0.001 0.034 0.184 0.219 0.091 0.432 0.066 
n 55 53 55 53 55 55 55 53 52 49 
Health
y 3m -      
S-FFQ 
3m 
ρ 0.246* 0.231* 0.279** 0.367** 0.141 0.221
* 
0.073 0.136 0.109 0.197 
p 0.020 0.028 0.008 0.000 0.188 0.036 0.499 0.213 0.316 0.072 
n 90 90 90 90 89 90 88 86 87 84 
Health
y 6m –    
S-FFQ 
6m 
ρ 0.207 0.096 -0.099 0.115 0.222* 0.102 0.123 0.077 -
0.042 
-
0.004 
p 0.062 0.389 0.601 0.547 0.045 0.360 0.269 0.491 0.708 0.972 
n 82 82 30 30 82 82 82 82 82 81 
Health
y 12m -    
S-FFQ 
12m 
ρ 0.222 0.078 0.097 0.172 0.174 0.205 0.100 0.138 0.001 0.083 
p 0.054 0.504 0.426 0.155 0.135 0.078 0.391 0.239 0.996 0.479 
n 76 76 70 70 75 75 75 75 75 75 
a: Dinner + spread + omega-3 supplement 
* p<0.05    
** p<0.001 
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7.3.1 ROUT-test  
Since there are some values that are well above the mean and median an outlier-test (ROUT) 
was perform to take out outliers and see if there were any difference in mean and median values 
with and without these (Table A.5, Figure A.1, Figure A.1 is made for easier visual 
comparison of median differences). 
The only significant differences in distribution between with and without ROUT-test are for 
PCB-118 for mothers at 28 weeks (p= 0.033, χ2(1)= 4,571) and PCB-138 (p=0.009, χ2(1)= 
6.914) for mothers at 3 months. At the most 7 values were taken out from a sample set, this was 
for PCB-118 for mothers at 6 months. 
 
 
Figure A.1 Rout-test median: Median of PCB-concentrations (PCB-118,-138,-153,-180) in ng/ml for 28th week in 
pregnancy and 3-, 6- and 12 months (m) after birth with and without ROUT-test. Mothers to the left and children to the right 
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Table A.5 Descriptive with and without outliers: Comparison of number of participants (n), mean, standard 
deviation (SD) and median PCB-118, -138, -153 and -180 before and after ROUT-test for mothers in 28th week in 
pregnancy, and for mothers and children at 3-, 6-, and 12 months after birth. 
 With outliers Without outliers 
 n Mean SD Median n Mean SD Median 
PCB 118         
Mother 28 weeks 61 0.03 0.02 0.03 60 0.03 0.01 0.03 
Mother 3 months 82 0.02 0.02 0.02 80 0.020 0.009 0.02 
 
Mother 6 months 85 0.02 0.02 0.02 78 0.020 0.009 0.02 
 
Mother 12 months 73 0.02 0.01 0.02 70 0.019 0.009 0.02 
Child 3 months 47 0.03 0.02 0.03 47 0.03 0.02 0.03 
Child 6 months 61 0.03 0.02 0.03 59 0.03 0.02 0.02 
Child 12 months 52 0.03 0.02 0.03 52 0.03 0.02 0.03 
PCB 138          
Mother 28 weeks 61 0.08 0.06 0.07 59 0.07 0.04 0.06 
Mother 3 months 82 0.06 0.06 0.04 76 0.04 0.03 0.04 
Mother 6 months 85 0.06 0.07 0.05 79 0.05 0.03 0.04 
Mother 12 months 73 0.06 0.04 0.05 71 0.05 0.03 0.05 
Child 3 months 47 0.08 0.06 0.06 45 0.07 0.05 0.06 
Child 6 months 61 0.07 0.06 0.05 59 0.06 0.05 0.05 
Child 12 months 52 0.08 0.09 0.06 51 0.07 0.06 0.06 
PCB 153          
Mother 28 weeks 61 0.14 0.08 0.13 60 0.13 0.06 0.13 
Mother 3 months 82 0.09 0.06 0.08 80 0.09 0.04 0.08 
Mother 6 months 85 0.10 0.09 0.08 83 0.09 0.06 0.08 
Mother 12 months 73 0.10 0.07 0.08 69 0.08 0.04 0.08 
Child 3 months 47 0.12 0.09 0.11 47 0.12 0.09 0.11 
Child 6 months 61 0.12 0.09 0.10 60 0.12 0.08 0.10 
Child 12 months 52 0.1 0.1 0.12 52 0.1 0.1 0.12 
PCB 180          
Mother 28 weeks 61 0.09 0.05 0.08 61 0.09 0.05 0.08 
Mother 3 months 82 0.07 0.05 0.06 79 0.06 0.03 0.06 
Mother 6 months 85 0.07 0.05 0.06 81 0.06 0.03 0.06 
Mother 12 months 73 0.07 0.06 0.06 69 0.06 0.03 0.06 
Child 3 months 47 0.07 0.05 0.06 46 0.07 0.05 0.06 
Child 6 months 61 0.08 0.06 0.07 61 0.08 0.06 0.07 
Child 12 months 52 0.1 0.1 0.06 51 0.08 0.06 0.06 
 
  
                                                     Appendix 3 
   
 
84 
 
 
 
 
  
41 53 47 46 60 51 45 56 48 45 56 49
6
8
5 1
1
1 2
5
4 2
5
3
0
20
40
60
80
1 2 3 4 5 6 7 8 9 10 11 12
F
re
q
u
e
n
c
y
 (
n
)
PCB-congeners at different time-points
Serie1 Serie2
60 70 71 57 61 82 85 73 61 80 82 71 61 82 85 72
1
12 14
16
0
0
0
0
0
2 3
2
0
0 0
1
0
20
40
60
80
100
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
F
re
q
u
e
n
c
y
 (
n
)
PCB-congeners at different time-points
Serie1 Serie2
Figure A.2 Mothers over/under PCB-LOQs: Serum samples above and below LOQ-values for mothers (M) for PCB-118,-
138,-153, and -180 at 28th week (w) in gestation, and 3, 6, and 12 months (m) after birth.  
Figure A.3 Children over/under PCB-LOQs: Serum samples above and below LOQ-values for children’s (C) for PCB-118,-
138,-153 and -180 at 3, 6, and 12 months (m) after birth.  
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Table A.6 Longitudinal differences in PCB-concentrations: Statistics with probability (p), number of mothers 
or children (n), test statistics (χ2) with degree of freedom in brackets, and median for the PCB-difference between 
28th week (w) in pregnancy, and 3, 6 or 12 months (m) after birth for PCB-118, -138,-153 and-180 for the 27 
mothers and for the 20 children 
 Mothers Children 
 PCB-
118 
PCB-
138 
PCB-
153 
PCB-
180 
PCB-
118 
PCB-
138 
PCB-
153 
PCB-
180 
Mediana 
28w .03 .08 .14 .10     
3m .02 .05 .08* .06 .02 .08 .1 .06 
6m .017* .05 .08** .06** .03 .06 .1 .08 
12m .02* .05 .08** .06** .03 .06 .1 .07 
Test Statisticsb 
n 27 27 27 27 20 20 20 20 
p 0.003 0.079 <0.001 <0.001 0.987 0.350 0.271 0.861 
χ2(3)  14.2 6.8 24.6 19.8     
χ2(2)     0.03 2.1 2.6 0.3 
         
Follow-upc 
28w-3m         
p >0.05 >0.05 0.013 >0.05     
χ2(1)   1.074      
28w-6m         
p 0.002 >0.05 <0.001 0.001     
χ2(1) 1.241  1.593 1.333     
28w-12m         
p 0.022 >0.05 <0.001 0.001     
χ2(1) 1.019  1.407 1.37     
a Median of the 27 valid mothers and 20 valid children 
b Friedman two-way analysis, test statistics is omitted for the children since there is no significance  
c Pairwise Follow-up test 
*Significant difference between this concentration and 28th week concentration, p≤0.05 
**Significant difference between this concentration and 28th week concentration, p≤0.001 
 
Table A.7 Differences in PCB-concentrations between mother and child: Statistics for the significant 
differences in PCB-concentrations between mother and child for PCB-118, -138 and -153 at 3 and 6 months, with 
probability (p) and test statistics (z or χ2). For Friedman test this includes degree of freedom in brackets behind the 
test statistics  
 Wilcoxon Signed Rank test Friedman Two-way test 
 p z p χ2(1) 
PCB-118: 3 months 0.005 -2.831   
PCB-138: 3 months 0.001 -3.445 0.014 6.095 
PCB-153 3 months 0.003 -2.945   
PCB-118: 6 months 0.007 -2.697   
PCB-138: 6 months 0.003 -2.952 0.014 6.333 
PCB-153 6 months 0.012 -2.504 0.033 4.751 
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Appendix 4: Analytical evaluation 
The analytical evaluation of the method is discussed in part 2.7 in the Material and Method 
section.  
Certified Reference Material (CRM) 
CRM bar graphs are found in Figure A.4-7, with concentrations for PCB-118, -138, -153 and 
-180 listed in Table A.8. Red bars in the figures are values above 130% of the true value plus 
the uncertainty value (U) and these also fail the t-test. Green bars are above 130% of the true 
value plus the uncertainty value, but passed the t-test.  
Table A.8 True value concentrations for certified reference material (CRM): with concentration in ng/g, 
uncertainty value (U), 30% of CRM minus U and 130% of CRM plus U for PCB-118, -138,-153 and -180 
Concentration (ng/g)       PCB118 PCB153 PCB138 PCB180 
True value 0,0185 0,0572 0,0369 0,0544 
U 0,0027 0,0033 0,0054 0,0013 
30%-U 0,00474 0,01617 0,00945 0,01593 
130% + U 0,02756 0,07865 0,05499 0,07241 
 
 
Figure A.4 CRM (SRM) for PCB-118 in ng/g for the different sample preparation dates. Parallels are denoted a and b. 
Lines are drawn in for concentrations representing 30% of the true value concentration minus the uncertainty value, 
and 130% of the true value concentration plus the uncertainty value. 
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Figure A.5 CRM (SRM) for PCB-138 in ng/g for the different sample preparation dates. Parallels are denoted a and b. 
Lines are drawn in for concentrations representing 30% recovery concentration minus the uncertainty value, and 130% 
recovery concentration plus the uncertainty value. 
 
 
 
Figure A.6 CRM (SRM) for PCB-153 in ng/g for the different sample preparation dates. Parallels are denoted a and b. 
Lines are drawn in for concentrations representing 30% recovery concentration minus the uncertainty value, and 130% 
recovery concentration plus the uncertainty value. 
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Figure A.7 CRM (SRM) for PCB-180 in ng/g for the different sample preparation dates. Parallels are denoted a and b. 
Lines are drawn in for concentrations representing 30% recovery concentration minus the uncertainty value, and 130% 
recovery concentration plus the uncertainty value. 
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Blank 
Bar graphs of blank-values measured in distilled water are found in Figure A8-11, with a 
suggested limit of 30% of the true value of the CRM drawn in. Orange bars are values above 
30% of the true CRM value. 
Table A.9 Blank values: Limit 30% of certified referende material (CRM): concentrations in ng/ml for 
PCB-118, -138, -153 and -180 
Concentration (ng/ml)            PCB118 PCB138 PCB153 PCB180 
30% of CRM 0,006 0,012 0,018 0,015 
 
 
Figure A.8 Blank-values (BL) for PCB-118 in ng/ml for the different sample preparation dates. Parallels are denoted a 
and b. Line is drawn in representing a concentration of 30% of the certified reference material. 
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Figure A.9 Blank-values (BL) for PCB-138 in ng/ml for the different sample preparation dates. Parallels are denoted a 
and b. Line is drawn in representing a concentration of 30% of the certified reference material. 
 
Figure A.10 Blank-values (BL) for PCB-153 in ng/ml for the different sample preparation dates. Parallels are denoted 
a and b. Line is drawn in representing a concentration of 30% of the certified reference material. 
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Figure A.11 Blank-values (BL) for PCB-180 in ng/ml for the different sample preparation dates. Parallels are denoted 
a and b. Line is drawn in representing a concentration of 30% of the certified reference material. 
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Standard 3 values  
Standard 3 results for PCB-118, -138, -153 and -180 from 18.11.2013 to 11.02.2014 (Figure 
A.15 to A.18.).  
 
 Figure A.12 PCB-118: Standard 3 used to ensure HRGC-HRMS calibration curve. Different analysis days are on the 
x-axis, concentration in ng/ml on the y-axis. Lines for +/- 2 and 3 standard deviations (sdev) from the true values are 
plotted in.  
 
Figure A.13 PCB-138: Standard 3 used to ensure HRGC-HRMS calibration curve. Different analysis days are on the 
x-axis, concentration in ng/ml on the y-axis. Lines for +/- 2 and 3 standard deviations (sdev) from the true values are 
plotted in. 
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Figure A.14 PCB-153: Standard 3 used to ensure HRGC-HRMS calibration curve. Different analysis days are on the 
x-axis, concentration in ng/ml on the y-axis. Lines for +/- 2 and 3 standard deviations (sdev) from the true values are 
plotted in. 
 
 
Figure A.15 PCB-180: Standard 3 used to ensure HRGC-HRMS calibration curve. Different analysis days are on the 
x-axis, concentration in ng/ml on the y-axis. Lines for +/- 2 and 3 standard deviations (sdev) from the true values are 
plotted in. 
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Appendix 5: Comparison between present study and other similar studies 
Table A.10 Comparison of present project with other similar studies: Concentration of PCB-118, -138, -153, 
-180 and summed PCB (138+153+180) (Sum PCB) in the present project and other similar studies. Present project: 
for mothers at 28th week (w) in gestation and for mother and child at 3-, 6-, and 12 months (m) after birth, for 
mothers showing levels under 30 years (y) of age, over 30 years of age and total.  Similar studies: at different times 
in life 
 Reference Country Age PCB-
118  
(ng/ml) 
PCB-
138 
(ng/ml) 
PCB-
153 
(ng/ml) 
PCB-
180  
(ng/ml) 
Sum 
PCB 
(ng/ml) 
Women  Present project * Norway 28w 
19-29y 
0.02 0.07 0.13 0.08 0.3 
30-41y 0.03 0.07 0.16 0.11 0.3 
19-41y 0.03 0.07 0.13 0.08 0.3 
 Present project * Norway 3m   
19-29y 
0.02 0.03 0.07 0.05 0.2 
30-42y 0.02 0.05 0.09 0.07 0.2 
19-42y 0.02 0.04 0.08 0.06 0.2 
 Present project * Norway 6m   
19-29y 
0.02 0.04 0.08 0.05 0.2 
30-42y 0.02 0.05 0.10 0.07 0.2 
19-42y 0.02 0.05 0.08 0.06 0.2 
 Present project* Norway 12m 
19-29y 
0.02 0.05 0.08 0.05 0.2 
30-42y 0.02 0.05 0.08 0.06 0.2 
19-42y 0.02 0.05 0.08 0.06 0.2 
Adults Morck et al., 2014* Denmark 31-52y - 0.121 0.181 0.024 0.326 
 Schulz et. al., 
2011c 
Germany 20-29y - 0.6 0.9 0.6 2.0 
30-39y - 0.9 1.6 1.0 3.2 
Infants Present project * Norway 3m 0.03 0.06 0.1 0.06 0.3 
 Present project * Norway 6m 0.03 0.05 0.1 0.07 0.3 
 Present project * Norway 12m 0.03 0.06 0.1 0.1 0.3 
 Walkowiak et al., 
2001* 
Germany 42 m - - - - 1.22 
 Lackmann, 2002b Germany Neonate - 0.5 0.5 0.4 1.4 
Children Grimalt et al., 
2010a 
Spain 4 y 0.10 0.24 0.35 0.20 0.79 
 Morck et al., 2014* Denmark 6-11 y - 0.086 0.118 0.072 0.276 
 Schulz et al., 2011c Germany 7-14 y - 0.3 0.4 0.3 1.0 
*Morck et al. (2014), Walkowiak et al. (Walkowiak et al., 2001), present project: median, ng/ml in serum samples  
 aGrimalt (Grimalt et al., 2010) : average in serum ng/ml 
bLackman (Lackmann, 2002): cord blood: 95th percentile: reference value 
cSchulz (Schulz et al., 2011): 95% confidence interval of 95th population percentile reference values from the German Human 
Biomonitoring Commission, whole blood samples 
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